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Abstract
In recent years there has been an intersection of supramolecular chemistry and ma-
terials science, with a particular focus on the controlled self-assembly of functional
building blocks. The impetus for assembly of organised architectures is a require-
ment due to organic electronic device performance being sensitive to the geometric
conﬁguration of adjacent molecular semiconductors, interacting by means of over-
lapping π-orbitals to create electronic conduction.
Inspired by the formation of elegant supramolecular structures in nature, this work
employs perylene bisimides coupled to synthetic peptides which are able to control
the assembly of chromophores in solution. Through examining the perturbations
of optical absorption and ﬂuorescence spectroscopic signatures, the presence of ag-
gregates, and also the geometric conﬁgurations of adjacent chromophores are deter-
mined. By exploring these features as a function of peptide design, pH, solvent com-
position, and ionic strength, it is demonstrated that aggregation is strongly induced
by the peptide and the aromatic core, with signiﬁcant dependence on the electro-
static repulsion between peptide segments. By manipulating solvent compositions,
we demonstrate the ability to induce controlled reorganisation of aggregates through
the introduction of charge onto the peptide sequence in high water concentration
solution. Furthermore, application of the exciton model to absorption spectra es-
tablishes the tuneability of aggregates by speciﬁc ion binding between neighbouring
peptides. Our results demonstrate the capability of peptide sequences to drive ag-
gregation of molecular semiconductor building blocks; moreover, the peptides allow
ﬁne tuning of the electronic overlap between neighbouring building blocks. The
proof of concept paves the way for further investigation into utilising this assembly
control for device fabrication, in particular, we see this work being applicable to
biosensor devices.
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Chapter 1
Background
1.1 Introduction
Electronic devices have become abundant in our everyday lives, with a constant
demand for increased device performance, and a decreased cost and size of each
device. These demands, coupled with the advent of novel electronic applications,
provide the impetus to continually enhance device performance. The incorporation
of π-conjugated systems as the active components in semiconductor devices has
lead to research in molecular semiconductors attracting a large amount of research
attention in the scientiﬁc community.1
One of the major challenges in the ﬁeld of organic electronics based on organic
molecules is the design of functional architectures which possess long range order.
Long range supramolecular assembly is a requirement due to device performance
relying on intermolecular electronic coupling of π-conjugated systems. Therefore,
eﬃcient organic semiconductor devices require a high degree of molecular organisa-
tion involving extended π-coupled networks which allow for strong π-π interactions.
The controlled formation of diﬀerent kinds of supramolecular architectures in so-
lution depends on a variety of factors, such as temperature, concentration, solvent
composition, molecular structure, particular additives, and the relative ratio of hy-
drophilic/hydrophobic domains.2–4 The controlled self-assembly of functional mate-
rials is obtained only through the precise balance of each of these forces. In light of
this challenge, inspiration can be gained from assembly methods utilised in nature
by investigating the ‘toolbox’ employed in these systems. There are numerous com-
plex functional supramolecular assemblies in nature, for example the double helix
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of DNA, or chlorophyll assemblies for light harvesting.5 One approach employed
to achieve supramolecular organisation of molecules on micrometer length scales is
through the use of synthetic peptide derivatives.6 Recently, this methodology has
gained considerable interest for the controlled assembly of π-conjugated materials,
for the end goal of device application.
Although there are numerous molecular semiconductors that have been reported
for various device applications,7 one interesting material that shows high promise
is that of perylene-3,4,9,10-tetracarboxylic bisimide, commonly known as perylene
bisimide (PBI).8 PBI derivatives are a promising component for organic electronic
device applications due to their optical and electronic properties, stability, and ease
of modiﬁcation.
This chapter provides a brief overview of PBIs and highlights not only the opto-
electronic properties, but also the molecular structure. A summary of the common
strategies that are employed in assembling PBI chromophores in solution are high-
lighted, and demonstrate the need to further investigate the controlled assembly
of PBIs for their use in optimised devices. One approach is to employ ‘nature’s
toolbox’ of assembly, namely the use of synthetic peptide assembly. To this end,
a review of the literature is presented highlighting the nanostructures commonly
observed with this approach. Finally, the reports of tethering peptide sequences
to other organic semiconductors is reviewed, which illustrates the need to further
explore this relatively recent approach to molecular assembly.
1.2 Perylene bisimides - a brief overview
The initial applications for PBIs were predominately as industrial pigments, due to
their inherent insolubility, thermal stability, light fastness, and chemical inertness.9
Recently, the applications of PBI derivatives are in the ﬁeld of electronic materi-
als, and are regarded as some of the best n-type semiconductors available, making
them promising for electronic applications.1 Studies of PBI have focussed on the
electron-accepting properties and subsequently PBI derivatives have found use in
organic light emitting diodes (OLEDS),10 photovoltaic devices,11 and ﬁeld eﬀect
transistors.12 This section introduces the structure, electronic and optical proper-
ties of PBI, highlighting the key features for the attention they have attracted in the
literature. Subsequently, a brief overview of the commonly employed methodologies
for inducing extended π-stacks of PBI chromophores is discussed.
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1.2.1 Structure and optoelectronic properties
The promising electronic properties of PBIs are a direct result of the structure of
the chromophore. Figure 1.1 illustrates the chemical structure of a generic PBI
derivative, highlighting two distinct sections that comprise the molecular structure.
One region is the planar π-conjugated core, known as perylene, containing ﬁve fused
aromatic rings. The bond lengths of this ring system, as determined from crystal
structures, show that it can be regarded as two fused naphthalene rings.13 The
second feature of the PBI molecule is the two electron withdrawing imide groups at
the 3, 4 and 9, 10 positions (see Figure 1.1).
12
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Figure 1.1 Chemical structure of N,N ′-dihydro PBI, showing the numbering of
the positions on the ring system.
The crystal packing of PBI dyes has been studied in the literature and have shown
the propensity of PBIs to form cofacial π-stacks in a parallel orientation at a distance
between 3.34 and 3.55 A˚ (compared to 3.55 A˚ for graphite).14 The propensity to form
strong π-π interactions is attributed to the inherit insolubility of PBIs. Although
this insolubility was initially exploited for use in pigments, favourable optical and
electronic properties lead intensive research into synthesising soluble PBI derivatives,
with the ﬁrst being reported by Langhals et al. in the 1990s.15 This was achieved
through the introduction of substituents on the PBI in order to inhibit aggregation
between chromophores, and thus increase solubility. This was motivated by crystal
packing investigations which showed that interaction of chromophores are sensitive
to steric requirements of substituents.16
There are two common positions on the PBI chromophore that are used to attach
various substituents; the ‘bay’ position, and the imide positions. The bay positions
are the carbons labelled 1, 6, 7, and 12 (Figure 1.1), whereas the imide positions are
the two nitrogen groups that comprise the imide moiety. Substitution at the imide
position has no eﬀect on disrupting the planar nature of the aromatic core. Whereas,
substitution at the bay position has been shown to cause propeller-like twisting of
the π-conjugated core.17 These reports demonstrate the ability to modulate the
nature of chromophore assembly through the introduction of substituents on the
PBI molecule.
One central factor for the research interest in PBI derivatives is the extraordinary
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lightfastness and intense yellow-green photoluminescence observed in the absence of
aggregation eﬀects. The molar extinction coeﬃcients of isolated PBI chromophores
typically approach 105 m−1 cm−1, and have the ﬂuorescence quantum yields near
unity.13 These photophysical properties are attributed to the fused aromatic rings
which form the π-conjugated core, which also has an optical band gap suitable for
use in organic devices.
Figure 1.2 shows an example of the absorption and emission spectrum of an isolated
PBI chromophore in solution. The lowest energy electronic transitions of PBIs are
between the ground state (S0) and ﬁrst excited state (S1), as shown in the Jablonksi
diagram. The vibronic progression observed in the spectra arises from the main
vibrational mode coupled to an electronic excitation of perylene being the C=C
stretch (approximately 1400 cm−1). This is depicted by the energy diagram which
correlates the peaks in the spectra to the corresponding electronic and vibrational
states of perylene (i.e., the 0–0, 0–1, and 0–2 transitions).
0-2
0-1
0-0
E
n
e
rg
y
S1
S0
Absorption Emission
0-2
0-1
0-0
Figure 1.2 (Left) Electronic absorption (solid line) and emission (dashed line)
spectrum of a typical isolated PBI chromophore. (Right) Jablonski diagram indi-
cating the cause of the vibronic progression. Figure adapted from S. R. Marder et
al.18
An important attribute of molecular semiconductors is that the optical spectro-
scopic signatures reﬂect the local environment of the chromophores, making optical
spectroscopy an excellent probe of the nature of chromophores in solution.19 Aggre-
gation is probed through analysing perturbations from the monomer spectrum that
occur upon the formation of eﬀective π-orbital electronic overlap between neigh-
bouring chromophores. This concept is central to the work covered in this thesis,
and is exploited to detect the presence of aggregates in solution as a result of sub-
stituents driving assembly. The details of this analysis is outside the scope of this
brief literature review, but will be covered in detail in Chapter 3.
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In order to exploit optical spectroscopy as a probe for the nature of chromophores in
solution, the electronic properties of the PBI core needs to be largely unaﬀected by
the substituents. This is because the perturbation of spectroscopic signatures needs
to be a result of aggregation eﬀects, and not from alterations to the π-conjugated
system itself. Figure 1.3 shows the highest occupied molecular orbital (HOMO) and
the lowest unoccupied molecular orbital (LUMO) for the electronic transition be-
tween the ground state (S0) and ﬁrst excited state (S1) for PBI.
20 Because nitrogen
atoms are located at nodes of the HOMO and LUMO, substituents at these posi-
tions impose little eﬀect on the electronic transition of perylene. Additionally the
symmetry of these orbitals means that the optical transition is polarised along the
molecular axis of the PBI, in other words, along the N–N axis.
HOMO LUMO
Figure 1.3 HOMO and LUMO frontier orbitals of N,N ′-dihydro PBI.20 Illustrat-
ing the nodes at the imide positions.
In contrast to the imide positions, the bay positions of PBI have signiﬁcant orbital
character; therefore substituents at these positions can impart changes to the ab-
sorption and emission properties of the PBI core. Based on the frontier orbitals,
substituents at the imide positions are favourable to inﬂuence aggregation due to the
negligible inﬂuence substituents at the imide positions have on the inherent optical
properties of PBI monomers.21 Therefore, any change in the optical spectroscopic
signatures of imide substituted chromophores are a direct result of the electronic
environment of the chromophore, and not caused by substituents changing the elec-
tronic properties of the PBI core.
1.2.2 Basics of assembly in solution
The ability to aﬀect the interaction of PBI chromophores in solution through the
use of imide substituents is an important concept that is exploited in PBI research.
Although some applications require the use of isolated chromophores, the discussion
here is limited to the common techniques employed to form supramolecular archi-
tectures of PBI assemblies. Examples selected in this review that highlight common
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approaches to PBI assembly. For a more detailed account, the reader is directed to
a number of comprehensive reviews.18,22
One of the simplest approaches of inducing aggregation of PBI in solution is through
the incorporation of alkyl chains at the imide substituent to increase the solubility
in nonpolar organic solvents. This generally results in isolated chromophores in so-
lution. Aggregation can be induced by changing the polarity of the solvent so that
assembly is induced in order for the system to reduce unfavourable solvent interac-
tions.23 Recently, this assembly approach has been shown to form PBI nanoﬁbres
which are able to form organogels,24 or be used in ﬁeld eﬀect transistors.25
An extension of this mode of self-assembly is to design PBI derivatives which are
strongly amphiphilic by incorporating polar substituents at the imide positions.
This increases the solvophobic/solvophilic forces that induce assembly upon solvent
polarity changes by the embedding the aromatic PBI core inside an aggregate.26
This mode of inducing aggregation has been shown to allow the formation of nanos-
tructures including nanobelts,27 nanotubes,28 and micelles/vesicles.29 However, one
diﬃculty that remains with these methods of inducing assembly is the prediction
as to the type of supramolecular architecture that will be formed. This task is
challenging due to a main driving force of aggregation in such systems being π-π
interactions of PBI cores, as this interaction lacks directionality. Furthermore, this
task is particularly challenging with amphiphilic building blocks in water, as the
hydrophobic force will have an extremely strong inﬂuence on aggregation.
One approach that has attracted considerable attention in the literature in recent
years is the incorporation of substituents that are able to form additional interac-
tions between molecules to complement π-π assembly.13 Interactions that have been
exploited include metal-ligand coordination,30 hydrogen bonding,31,32 and ionic as-
sembly.33 Covalent interactions (i.e., metal-ligand coordination) add directionality
towards aggregation, but lacks the ability for aggregates to be tuned due to the
permanent nature of bond formation. In contrast, ionic assembly is a weak inter-
molecular interaction which allows for controlled tuning of aggregation, but is unable
to promote directional assembly of molecules.
One example of noncovalent interactions controlling PBI assembly which has re-
ceived considerable attention in the literature is that of triple H-bond formation of
melamine and cyanurate/barbiturate derivatives.34,35 This triple H-bond formation
has been shown to form strong networks, reminiscent of that observed in DNA base
pairing in the ﬁeld of supramolecular assembly, illustrating the directionality im-
posed on aggregation.36 Figure 1.4 shows how this interaction is employed in the
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PBI literature. Typically a melamine motif is incorporated as an imide substituent
on a PBI derivative, and upon addition of a cyanurate moiety to solution, complex-
ation can occur to induce assembly of chromophores.
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Figure 1.4 Generic PBI derivative which contains a melamine motif (blue) and the
triple H-bond complexation with a cyanurate derivative (green) to induce assembly.
Figure adapted from Wu¨rthner et al.35
This approach therefore involves the addition of guest molecules in order to induce
assembly, as opposed to self-assembly in solution. Recently, a study by Seki et al.
reported the use of this approach to obtain organised lamellar architectures of PBI
molecules.37 In this study, the authors deposited these assemblies onto Si/SiO2 sub-
strate via spin coating for use in organic ﬁeld eﬀect transistors devices. However,
the device exhibited poor performance, well below practical use. This highlights the
need for further investigation on the controlled assembly of PBI chromophores in
order for use in electronic applications. Current interest in the PBI literature is cen-
tred on obtaining precise control of π-π stacking to form organised supramolecular
structures. The impetus for this is the drive to improve charge transport properties,
which is of fundamental importance in applications of π-conjugated materials in
optoelectronic devices.
1.3 Organic semiconductor self-assembly through
nature mimics
Nature has perfected the controlled self-assembly of molecules via non-covalent in-
teractions to achieve elegant structures such as the double helix of DNA and chloro-
phyll assemblies for light harvesting.5 The principles employed in nature to assemble
complex structures has provided the incentive for scientists to attempt to mimic the
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formation of complex assemblies.1,38 This is commonly investigated through manip-
ulating noncovalent intermolecular interactions such as; hydrogen-bonding,39 π-π
interactions,40 electrostatic interactions,41 or solvophobic eﬀects.42
Considerable attention in recent years has been devoted to the incorporation of
organic semiconductors in DNA based assemblies.43,44 However, this approach is
predominantly concerned with gaining a better understanding of the structure of
biological materials through biolabelling.22,45 This assembly approach falls outside
the scope of this work and is omitted from discussion, with the reader directed to a
recent review article that explores the relevant concepts in detail.46
Of interest here is the conﬁgurational speciﬁcity of proteins, motivating synthetic
peptides to emerge as a promising class of compounds as templates for the assembly
of molecules.47,48 Further promise is gained from the ability to synthesise peptides
using well established, and conventional, methods, namely solid phase peptide syn-
thesis.49 This section provides a brief review of key results obtained through inves-
tigations on peptide-templated assembly of peptide amphiphile molecules reported
in the literature. To this end, a review of recent work reported in the literature on
the peptide-mediated assembly of functional materials are highlighted.
1.3.1 Principles of self-assembling peptide amphiphiles
Investigations into peptide driven assembly was inspired by Stupp et al. in 2001
who showed that peptide sequences with a hydrophobic tail assembled into nanoﬁ-
bres.48 This class of compounds are known as peptide amphiphiles, due to their
structural properties resembling those of amphiphilic surfactant molecules; namely
a hydrophobic tail bound to a hydrophilic head group. These types of molecules
have been shown to form a variety of supramolecular structures; including tubes,50
ribbons,51 and micelles/vesicles.52 This is achieved through the combination of H-
bonding, hydrophobic, and electrostatic interactions and varying the balance of these
forces in solution.53
Figure 1.5 shows the general structure that is incorporated into the supramolecular
design of peptide amphiphiles, and highlights four key structural elements that are
commonly employed.6 Region 1 consists of a hydrophobic domain, for example an
alkyl tail of some length ‘n’. Region 2 consists of a short peptide sequence that is
capable of forming intermolecular H-bonds. Region 3 contains ionisable amino acids,
which increases the solubility of the peptide molecule in aqueous environments.
Region 4 is a domain that can add biological speciﬁcity, for example the inclusion
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of a particular amino acid sequence that can interact with cells or proteins.54
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Figure 1.5 General molecular structure of a peptide amphiphile, indicating the
common 4 regions that are commonly incorporated in the supramolecular design.
The amphiphilic nature of the molecule is an important characteristic, with studies
demonstrating that long alkyl chains promote aggregation due to strong hydrophobic
interactions when dispersed in water.55 This is reminscent of surfactant assembly,
in which micelles and vesicles are commonly observed to embed the hydrophobic
segment inside to reduce unfavourable interactions with the solvent.56 The inclusion
of ionisable amino acids in the peptide sequence results in nanostructures formed
from peptide amphiphiles that are sensitive to pH and salt additions.6
This sensitivity is based on the the fact that a change in pH (or ionic strength),
modulates the extent of electrostatic repulsions that can occur between neighbouring
peptide molecules, which hinders spontaneous assembly. Additionally, studies have
been reported which exploit the ionisable amino acid residues through the coassem-
bly of peptide amphiphiles which have oppositely charged groups. In these systems,
aggregation is induced based on the electrostatic attraction between molecules in
solution.57,58 Such studies demonstrate the inﬂuence that electrostatic interactions
have on the self-assembly of peptide molecules in solution.
One of the central driving forces that drives peptide nanostructure assembly in
solution is a result of the amino acids in Region 2, which are capable of forming in-
termolecular H-bonds, typically in the form of a β-sheet.6 An important study was
conducted in 2006 by Paramonov et al. which investigated the role of H-bonding
on the formation of peptide amphiphile nanostructures.59 The authors probed this
by sequentially inhibiting H-bond formation at various positions of a peptide am-
phiphile, through N-methylation of glycine (Gly) residues.
The ﬁndings from that study are summarised in Table 1.1, along with the general
structure of the peptide amphiphile that was used by the authors. The inﬂuence
of H-bonding was extracted through visualisation of nanostructures formed using
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cryogenic transmission electron microscopy (cryo-TEM). Speciﬁcally, this was used
to investigate what eﬀects N-methylation had on disrupting nanoﬁbre formation of
the peptide amphiphile. In order to gain further insight into the relative strength of
nanoﬁbre interactions, the authors investigated the rheology of any solvent gelation
that occurred. This gelation is a common observation in peptide amphiphile re-
search, and is a result of a 3D-network of ﬁbres forming which is able to trap solvent
molecules.60
The ﬁrst series of peptide amphiphiles investigated by Paramonov et al. (A–H)
study the eﬀect of sequentially increasing the number of N-methylated glycine
residues, and therefore decreasing the ability of the molecules to form intermolec-
ular H-bonds. The results showed that as H-bonding was inhibited close to the
hydrophobic tail, the nanostructures changed from nanoﬁbres to spherical micelles,
as observed in cryo-TEM. This observation was supported by a weakening of the
resulting gel, and eventually no stable gel being formed once spherical micelles were
the dominant structures. The lack of gelation is rationalised based on the fact that
micelles are unable to form long range order to trap solvent molecules, whereas
such an interaction is possible through the entanglement of ﬁbres in a nanoﬁbre
structure.61
The second series of peptide amphiphiles in the study (H, I and O–S) investigated
the sequential N-methylation in the opposite direction to the previous series (starting
at position 1). The cryo-TEM studies showed that the nanostructures formed for all
peptide amphiphiles were spherical micelles, thereby illustrating that N-methylation
close to the hydrophobic domain prevents ﬁbre formation. This indicates the im-
portance of H-bonding, and its speciﬁc location on the monomer, in directing the
self-assembly into well deﬁned ﬁbres.
The study by Paramonov et al. interrogated the role of H-bonding further and ex-
plored the eﬀects of having only one N-methylated glycine per peptide amphiphile
(I–N). As observed by cryo-TEM, all peptide amphiphiles in this series assemble
into ﬁbres indicating that single methylation does not prevent nanoﬁbre forma-
tion. However, when mechanical investigations were carried out, it became clear
that although nanoﬁbres were formed regardless of which glycine position was N-
methylated, positions close to the core were unable to form stable gels, indicating a
lack of interactions between ﬁbrils in solution.
The ﬁndings from this study lead the authors to three conclusions as to the role of
H-bonding in peptide amphiphile assembly; 1) Methylation in glycine positions 1–4
completely eliminates the ability for the ﬁbres to network causing hydrogelation,
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Table 1.1 Summary of N-methylated peptide amphiphiles prepared in the 2006
study of Paramonov et al.59 Also included is the structure of the peptide amphiphile
used in the study.
Gly
O
Gly Gly Gly Gly Gly Gly Glu Arg Gly Asp Ser
9
Position of gly residues
1 2 3 4 5 6 7
Glycine Position a
PA 1 2 3 4 5 6 7 nanostructure b rheology c
A G G G G G G G F Gel
B G G G G G G NMeG F Gel
C G G G G G NMeG NMeG F Gel
D G G G G NMeG NMeG NMeG F wGel
E G G G NMeG NMeG NMeG NMeG — —
F G G NMeG NMeG NMeG NMeG NMeG — —
G G NMeG NMeG NMeG NMeG NMeG NMeG — —
H NMeG NMeG NMeG NMeG NMeG NMeG NMeG — —
I NMeG G G G G G G F —
J G NMeG G G G G G F —
K G G NMeG G G G G F —
L G G G NMeG G G G F —
M G G G G NMeG G G F Gel
N G G G G G NMeG G F Gel
O NMeG NMeG G G G G G — —
P NMeG NMeG NMeG G G G G — —
Q NMeG NMeG NMeG NMeG G G G — —
R NMeG NMeG NMeG NMeG NMeG G G — —
S NMeG NMeG NMeG NMeG NMeG NMeG G — —
aG indicates a standard glycine, NMeG indicates an N-methylated glycine residue was used.
b‘F’ indicates the presence of nanofibres as the dominant structure (as observed from cryo-
TEM), ‘—’ indicates no fibres were observed, but rather spherical micelles.
cBased on rheology data, either a Gel or wGel (weak gel) was observed, ‘—’ indicates no gel
was formed.
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2) Two or more methylations of glycine positions 1–4 eliminates ﬁbre formation
entirely and instead spherical micelles are formed, and 3) Any methylations of glycine
positions 5–7 will decrease the strength of a resulting gel, but will not explicitly
eliminate the formation of nanoﬁbres.59
Therefore, it is apparent that H-bonding plays a signiﬁcant role in the formation
of peptide amphiphile nanostructures in solution. Without the ability to form such
noncovalent intermolecular interactions, the assemblies observed appear to behave
like traditional surfactant assemblies, thereby demonstrating that H-bonding is able
to complement the hydrophobic driving force of assembly for amphiphilic molecules.
1.3.2 Peptide templated assembly of molecular semiconduc-
tors
The formation of well deﬁned nanoﬁbres using synthetic peptide molecules is a signif-
icant result that has promise for the organisation of molecules in functional materials.
The motivation to select an organic semiconductor as the hydrophobic segment of
a peptide amphiphile is driven by the promise H-bonding has to complement π-π
assembly,62 enabling organised supramolecular structures which is fundamental for
optimal performance in optoelectronic devices.
One class of organic semiconductors which has received considerable attention in
research pertaining to device fabrication are oligo- and polythiophene derivatives.
The interest in these compounds is motivated by the success such moieties have had
in the ﬁeld of organic electronics.1 The ﬁrst peptide-oligothiophene derivative was
reported in 2004 by Klok et al. ,63 which incorporated a pentapeptide sequence of
alternating glycine and alanine residues. These repeating amino acid residues have a
high propensity to form intermolecular H-bonds, exploited in nature by the Bombyx
mori (silk worm), of which the repeating glycine/alanine unit has been identiﬁed as
the most important repeat sequence contributing to the strength of the ﬁbre.64
The results obtained by Klok et al. demonstrated that peptide sequences appeared
to be able to control the nanostructure of the oligothiophene, thereby altering the
electronic properties of the organic semiconductor. However, one drawback to novel
oligothiophenes derivatives is the diﬃculty of synthetic procedures required for de-
rivitisation.65 Nevertheless, this is proof of concept that a peptide sequence can
modulate the photophysics of a molecular semiconductor and has provided the im-
petus for the inclusion of various other π-conjugated materials in peptide systems.
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A study by Ma et al. utilised three diﬀerent π-conjugated materials, that were eas-
ily tethered to a peptide sequence.66 This study investigated the eﬀect a variety of
pentapeptide sequences had on the assembly of π-conjugated materials, with a focus
on exploring supramolecular hydrogelation. Figure 1.6 shows the synthetic protocol
utilised in this study, highlighting the direct incorporation of ﬂuorene (F), pyrene
(P), and naphthalene (N) derivatives with solid phase peptide synthesis. This simple
one step reaction to couple a peptide sequence to a molecular semiconductor is sig-
niﬁcant advantage for electronic device fabrication. Although, these π-conjugates
molecules have found limited use in organic electronics, largely attributed to the
wide band gap of these chromophores.67,68
Figure 1.6 Synthesis of diﬀerent ﬂurophore-peptide conjugates using ﬂuorene (F),
pyrene (P), and naphthalene (N) derivatives. i) 88% triﬂuoroacetic acid, 2% i-
Pr3SiH, 5% phenol, and 5% H2O, ii) 20% piperidine in DMF, and iii) HBTU/HOBt,
DIEA, DMF. Figure adapted from Ma et al.66
The photophysics reported for each of the ﬂuorophores-peptide conjugates illustrated
that upon inducing aggregation in solution (through heating to 70 ◦C and then cool-
ing), signiﬁcant π-orbital electronic overlap occurs between chromophores, evident
through photoluminescence quenching and excimer formation. Furthermore, TEM
images showed the presence of self-assembled ﬁbres in cryo-dried hydrogels. The re-
sults from Ma et al. found that through balancing the combination of hydrophobic
demands of the chromophore, together with favourable π-π interactions in water,
these forces were able to complement H-bonded directed assembly demonstrating
the ability to drive aggregation of π-conjugated materials through balancing various
forces acting on the system.
With the desire to use relatively straightforward synthetic techniques to exploit pep-
tide assembly with molecular semiconductors for device applications, the utilisation
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of chromophore derivatives has come to the fore. Recently, Parquette et al. reported
the synthesis of three dipeptide napthalene bisimide (NBI) derivatives, depicted in
Figure 1.7.69 In these derivatives, assembly is strongly promoted in aqueous media
through increasing the hydrophobicity of the molecule. This study illustrates once
more the importance of balancing the various forces that can drive self-assembly in
solution.
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Figure 1.7 Design and structure of a naphthalene bisimide dipeptide conjugate.
Figure adapted from Parquette et al.
The study by Parquette et al. presents TEM, and optical spectroscopy data that
show the ﬂuorenyl containing NBI-dipeptide conjugate exhibited solvent dependent
aggregation. When a solvent was used that could satisfy the hydrophobic demands,
such as 2,2,2-triﬂuoroethanol (TFE), isolated chromophores were present. However,
when the NBI-dipeptide conjugate was dispersed in water, 1D nanoﬁbres were ob-
served. Furthermore, the spectroscopic perturbation from monomer signatures in
the absorption spectrum of NBI chromophores, together with the strong photolu-
minescence quenching (15-fold) suggests the formation of co-facial NBI assemblies
within the nanoﬁbres.13 The peptide segment within the nanoﬁbres possessed β-
sheet H-bonding character, while assembly to the point of insolubility is prevented
due to electrostatic repulsion between dipeptide segments.69
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1.4 Summary
This summary of the literature highlights the tethering of a peptide sequence to
three organic semiconductors; namely pyrene, naphthalene, and ﬂuorene moieties.
These are the most commonly employed semiconductors that are investigated for
the controlled assembly in solution through the use of peptide amphiphiles. These
results illustrate the ability to modulate the assembly of π-conjugated molecules
through the use of peptide assembly. However, the organic semiconductors used
have had limited success in the ﬁeld of organic electronics, largely attributed to their
wide band gap. This highlights the need for further development in the ﬁeld, with
the extension to organic semiconductors which show a greater promise in device
applications, due to more favourable optical and electronic properties. One such
material is PBI, which has a relatively low optical band gap in comparison. Such
peptide controlled assembly has not yet been explored for PBI.
1.5 Research aims
The overall goal of this research is to explore the controlled assembly of PBI chro-
mophores in solution through the use of peptide directed assembly. Firstly, synthetic
peptide sequences are to be tethered symmetrically to PBI at the imide position
(Chapter 2). The use of imide substitution is motivated by the negligible inﬂuence
substitution at this position has on the optical and electronic properties of the PBI
core. As a result, optical spectroscopy is able to be used as a probe of the local
electronic environment of PBI chromophores to determine the presence, and type,
of aggregates in solution (Chapter 3).
The second goal of this research was to then investigate the tuneability of PBI
aggregates in solution, through varying solvent mixtures (Chapter 4), and counterion
additives (Chapter 5). The motivation for this research is the promise that controlled
assembly of PBI chromophores could lead to applications in the ﬁeld of organic
biosensors, or the development of other novel devices.
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Chapter 2
Synthesis and molecular design of
peptide-PBI derivatives
2.1 Introduction
Nature has accomplished the assembly of building blocks into supramolecular archi-
tectures, such as chlorophyll assemblies for light harvesting.5 Such systems provide
the motivation for the design of novel molecular building blocks which are capable
of mimicking the intermolecular interactions that are employed in nature. This is
commonly investigated through the incorporation of functional groups into building
blocks which allow the manipulation of noncovalent intermolecular interactions such
as; hydrogen-bonding (H-bonding),39 π-π electronic overlap,40 electrostatic interac-
tions,41 solvophobic eﬀects,42 or steric inhibition.70
By designing molecular building blocks to contain motifs with the potential to form
these noncovalent intermolecular interactions, it is possible to control the self assem-
bly and form supramolecular structures. This work investigates the incorporation
of a peptide sequence as imide substituents on a PBI core. Through modifying the
design of the peptide sequence, a PBI conjugate library was obtained (Figure 2.1) in
order to deduce the inﬂuence the peptide sequence has on the assembly in solution.
This chapter also presents the synthetic protocols employed in order to obtain a pep-
tide sequence symmetrically tethered to a PBI core, which was achieved in a two-step
synthetic procedure, and highlights key structural characterisation data to conﬁrm
the identity of PBI derivatives. Firstly the peptide precursors (1, 2, 3, 4, 5) were
synthesised, and subsequently tethered to a PBI core to form the various peptide-
PBI conjugates (6, 7, 8, 9, 10). In a similar fashion, a reference compound was
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synthesised (alkyl-PBI 11) by coupling an alkyl chain to the PBI core to reference
various optical spectroscopy measurements conducted in this work.
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Peptide Precursors Peptide-PBI Conjugates
Reference Compound
Figure 2.1 Library of compounds synthesised, illustrating the peptide precursors
(1–5), peptide-PBI conjugates (6–10), and the alkyl-PBI compound (11). Note,
Gly, Ala, Leu, and Glu represent glycine, alanine, leucine, and glutamic acid (re-
spectively).
2.2 Molecular design of peptide-PBI library
The stepwise assembly of the peptides (through solid phase peptide synthesis, dis-
cussed below), allowed for signiﬁcant control over the type and sequence of amino
acids used in the synthesis. Through modifying the amino acid residues that com-
prise the peptide sequence, three structural regions were made to inﬂuence the as-
sembly of PBI cores. Since this process is discussed thoroughly in Chapter 3, the
discussion here is reserved for the variations of peptide design, and the rationale to
diﬀerent design aspects of the peptide-PBI conjugates.
The library of compounds synthesised (illustrated in Figure 2.1), shows that the only
PBI-derivative that does not possess a peptide sequence is the reference compound,
alkyl-PBI 11. Instead, this compound contains a straight chain alkyl substituent at
each imide nitrogen, reducing its chemical functionality so as to prevent a driving of
assembly through weak intermolecular interactions, for example hydrogen-bonding
(H-bonding) of amide and carbonyl functional groups. Long alkyl chains symmetri-
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cally tethered to the PBI core results in a structure comprised of non-polar function-
ality and is therefore readily soluble in organic solvents. This compound provides a
reference for absorption and emission characteristics of isolated PBI chromophores
(in chloroform (CHCl3)). Such information will be utilised in this work when optical
spectroscopy is used to probe the aggregation of peptide-PBI conjugates in solution,
which is introduced in Chapter 3.
This means that the main design modiﬁcations of the library are concerned with
the peptide-PBI conjugates. Arguably, the most important design feature of these
compounds is the diverse solvation demands imposed by the large hydrophobic PBI
core coupled to a hydrophilic peptide, generating amphiphilic character. An impli-
cation of this amphiphilic character is that solvophobic forces are expected to aid in
driving the self-assembly in aqueous solution, in order to reduce unfavourable inter-
actions. The second design element is concerned with the speciﬁc peptide precursor
sequence tethered to the PBI core. Peptide segments in this work comprise three
key structural features (illustrated in Figure 2.2) and are inspired from reports in
the literature regarding self-assembled peptide amphiphiles.6 These key structural
features are represented in three distinct regions of the peptide sequence. Through
changing the amino acid residues in these key regions, the role of the peptide on self
assembly can be deduced.
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Figure 2.2 Molecular structure of a representative peptide segment showing three
distinct chemical regions incorporated in the library of compounds.
One design feature that remains constant in all peptide sequences is the glycine
in region 1. This amino acid residue with low steric demand is incorporated at
this position in order to reduce possible steric inhibition of the amine condensation
between the terminal NH2 and PTCDA. A sterically bulky group in this position
could hinder the rate of nucleophilic attack of the anhydride ring of PTCDA. The
second design element is the short amino acid sequence in region 2, which consists of
a short peptide sequence that contains amino acids with either a high propensity to
form intermolecular hydrogen bonds, or have high steric demands of the side chain.
The third element incorporated into the design of peptide sequences is the addition
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of amino acids with ionisable side chains, in region 3. These groups increase the
solubility of peptide-PBI conjugates in aqueous solvents because the ionised form
of these groups increases the hydrophilic nature of the compound. As a result, the
solubility, and hence the potential driving force of assembly, becomes sensitive to
the pH and presence of ions in aqueous solution. Noteworthy, only glutamic acid
residues (weak acids, charged at basic pH) were used in region 3 of all peptide-
PBI conjugates. The use of weak bases (charged at acidic pH), for example lysine
residues, complicates the amine condensation (used in the synthetic procedure) due
to each side chain having a terminal NH2 group. Additional NH2 groups on the pep-
tide sequence can lead to side reactions due to nucleophilic attack on the anhydride
of PTCDA from numerous NH2 groups.
Figure 2.3 illustrates the modiﬁcation of the peptide design incorporated into the
PBI conjugate library. Peptide-PBI 6 is used as an initial peptide sequence to
begin experimental proceedings. There are three types of modiﬁcations made to
the peptide sequences, namely the incorporation of a region capable of H-bonding
(peptide-PBI 7 and 8), reduced number of ionisable amino acids (peptide-PBI 9),
and increased steric demand close to the PBI core (peptide-PBI 10). Firstly, the
peptide segment in peptide-PBI 6 has the principal exclusion of region two (discussed
above) containing only one glycine (Gly) and three glutamic acid (Glu) residues,
resulting in the charged amino acid residues being in close proximity to the PBI
core. This peptide design aims to examine the inﬂuence of ionisable amino acid
groups, and if the proximity to the PBI core has any large inﬂuence on the nature
of aggregates formed.
The incorporation of three glycine or alanine (Ala) amino acid residues increases
the length of the peptide sequence and introduces a section capable of forming
intermolecular H-bonds (i.e., peptide-PBI 7 and 8). These peptide sequences aim
to elucidate the role intermolecular H-bonding has on the self assembly of peptide-
PBI conjugates, and whether the addition of this interaction is able to ‘knit’ them
together and enhance aggregate formation. Peptide-PBI 9 contains a similar peptide
sequence to those with a H-bonding segment, however the notable diﬀerence is the
reduction in the number of glutamic acid residues (from three to one). This peptide
design, with a reduced number of ionisable carboxylic acid groups, aims to elucidate
the inﬂuence electrostatic repulsion between ionised peptide sequences has on the
self-assembly of peptide-PBI conjugates. This can be achieved through comparing
the nature of aggregates formed by peptide-PBI 8, which contains all three glutamic
acid residues in the peptide sequence.
The ﬁnal design modiﬁcation conducted in this study was the inclusion of leucine
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Figure 2.3 Diﬀerent types of peptide modiﬁcations employed in the peptide seg-
ment of peptide-PBI conjugates in order to probe the inﬂuence the peptide has on
PBI assembly.
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(Leu) amino acids into region 2 of the peptide, to obtain peptide-PBI 10. These
amino acids contain an isopropyl- (iPr) group, causing moderate steric demands
near the PBI core compared to peptide-PBI 7 or 8. This peptide design aims to
deduce what eﬀect increasing the steric bulk has on aggregation. For example, if
the aggregation could be hindered or altered in order to accommodate the possible
steric interactions. This can be deduced through the comparison of peptide-PBI 7
and 8 aggregates in solution, which lack the steric demands imposed on peptide-PBI
10.
2.3 Synthesis and structural characterisation
The ﬁrst stage in the synthesis of peptide-PBI conjugates was to synthesise the pep-
tide to later be tethered to the PBI core. This was achieved using ﬂuorenylmethyl-
oxycarbonyl (Fmoc)-mediated solid phase peptide synthesis (SPPS), of which the
protocol is well established in the literature.49 The general procedure for SPPS in-
volves the stepwise assembly of a peptide through consecutive coupling of amino
acid residues, through the use of a solid resin support.
One of the most important advantages of SPPS compared to solution phase syn-
thesis is that the coupling of amino acids to be carried out more rapidly and near
completion. This is possible because the reagents used in the coupling reaction can
be used in excess, and removed simply by washing after each reaction step. The
ability to wash away reagents or cleaved protecting groups largely contributes to the
high yields and good purity of peptides obtained via this method.71,72 The struc-
tural identity of the peptide precursors was conﬁrmed through nuclear magnetic
resonance (NMR) and mass spectrometry (MS) techniques, which indicated high
purity therefore allowing the peptides to be used in subsequent reactions without
further puriﬁcation.
The next stage of the synthesis of peptide-PBI conjugates was to couple the peptide
sequence to a perylene core. This was achieved through the condensation reaction
of perylene-3,4,9,10-tetracarboxylic dianhydride (PTCDA) and the primary amine
of each peptide precursor (illustrated in Scheme 2.1). This method, developed by
Langhals et al. in the 1990s,15 is the most commonly employed approach to syn-
thesise symmetrically N,N ′-substituted PBI derivatives, and generally involves high
reaction temperatures (≥ 140 ◦C) in solvents such as molten imidazole or quinoline
under an inert atmosphere.18 There is high compatibility between the amine con-
densation reaction and the peptide (obtained from SPPS), due to the condensation
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reaction in principle allowing any molecule possessing a single primary amine to
attach to the PBI core. All PBI conjugates were obtained through this procedure,
with the R group either being a peptide (for the synthesis of peptide-PBI conju-
gates) or a alkyl chain (for the synthesis of the reference compound 11).
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PTCDA Peptide-PBI conjugate
Scheme 2.1 Amine condensation of PTCDA with a primary amine, for the syn-
thesis of peptide-PBI conjugates, R=peptide sequence.
The resulting peptide-PBI conjugates were subsequently puriﬁed using reverse phase
column chromatography, and were obtained in good yields (70–85%, exact yields are
presented in Chapter 8). The characterisation of the peptide-PBI conjugate library
was made challenging due to the poor solubility of these compounds in many or-
ganic solvents, which signiﬁcantly hindered nuclear magnetic resonance (NMR) and
mass spectrometry (MS) experiments. Nevertheless, the structures were conﬁrmed
through the combination of 1-D and 2-D NMR, matrix assisted laser desorption
ionisation MS (MALDI-MS), and Fourier transform infrared (FTIR) spectrocsopy
experiments. Key structural characteriation data will be highlighted here, using one
peptide-PBI conjugate as an example, namely peptide-PBI 8.
Firstly, the data obtained from FTIR spectroscopy provides key evidence for the
success of the amine condensation with PTCDA. Figure 2.4 shows the FTIR spec-
trum of peptide-PBI 8 between 2000–400 cm−1, with the key stretching frequencies
labelled. This FTIR spectrum shows the disappearance of the characteristic anhy-
dride carbonyl stretching band (1774 cm−1), and the appearance of the N -imide
carbonyl stretching band at 1661 cm−1. Similarly, the C–O–C stretching band of
the anhydride (1025 cm−1) has disappeared and been replaced by the C–N stretch-
ing band of the imide at 1366 cm−1. These spectral features indicate the conversion
of the anhydride on PTCDA, to an imide on PBI. Additionally, the presence of
the characteristic amide II band of secondary N-H bending (1544 cm−1) provides
evidence for the presence of the peptide sequence in the material.
This information indicates the success of the PTCDA/peptide condensation reac-
tion. However, further characterisation information was required in order to con-
ﬁrm the structural identity. This was obtained through the use of MALDI-MS,
which yielded the expected mass-to-charge ratio for each peptide-PBI conjugate (see
Chapter 8). Further supporting evidence was obtained upon performing an MS-MS
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Figure 2.4 FTIR spectrum of peptide-PBI 8 showing the change in stretching fre-
quencies to PTCDA. The disappearance of anhydride stretches and the appearance
of imide stretches indicates imide formation.
spectrum and analysing the fragmentation of the peptide-PBI conjugate, which ex-
hibited the expected fragmentation of the peptide sequence. Finally, the structural
identity was conclusively conﬁrmed through the use of NMR experiments, in partic-
ular through the use of HMBC (Heteronuclear Multiple Bond Correlation), HSQC
(Heteronuclear Single Quantum Coherence), and COSY (homonuclear correlation
spectroscopy) experiments.
Each of these NMR experiments are 2-dimensional and allow diﬀerent structural in-
formation to be elucidated based on the observations of correlations between atoms
in the molecule. A 1H-1H COSY experiment exhibits correlation signals when pro-
tons are spin-spin coupled, i.e., a signal is observed when there is a proton-to-proton
interaction. In an HSQC experiment, correlations are observed between nuclei of
two diﬀerent types which are separated by one bond. The particular experiment
used in this work investigated the correlations between the chemical shift of a pro-
ton with the chemical shift of a directly bound carbon. An HMBC experiment
diﬀers from an HSQC in that the heteronuclear couplings are detected over a longer
range, typically 2–4 bonds. In this work, HMBC correlations between protons and
carbons, which are two or three bonds away, were utilised in structure conﬁrmation.
Figure 2.5 shows a small section of peptide-PBI 8 (used as an example) highlighting
the correlations that conﬁrm the link between the peptide sequence and the PBI
core. The connection of these two building blocks is conﬁrmed upon the observation
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of an HMBC correlation from the H5 protons (i.e., the protons attached to C5) to
C3 (i.e., the PBI carbonyl carbon). For this to be achieved, the ﬁrst task was to
determine the chemical shift of H5 protons by assigning the chemical shifts along
the peptide chain, through the combination of HSQC, HMBC, and COSY data.
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Figure 2.5 Structure of peptide-PBI 8 showing the HMBC and COSY correlations
which conﬁrming the coupling of a peptide sequence to the PBI core.
The HSQC correlation between H8 and C8 conﬁrmed the direct bond between these
two atoms. Furthermore, there was a COSY correlation between H8 and H9 protons
(methyl group protons), and an HMBC correlation between H9 and C8. These
correlations indicate that C8 is part of an alanine residue. The elucidation of the
exact alanine residue was achieved through noting an HMBC correlations from H8
to both C10 and to C6, consistent with these atoms being two or three bonds apart.
Although there were no HMBC correlations observed from H7 to any neighbouring
carbon atoms in peptide-PBI 8, such correlations were observed in the peptide-
precursor (peptide 3). This leads one to believe that this N–H is still present in the
sequence based on the expected mass obtained from MS, and the HMBC from H8
to C6, through N7.
The observation of HMBC correlation from the protons on C5 (i.e., Ha and Hb) to
C6 show that this glycine residue is the next amino acid along the chain. These two
protons show diﬀerent chemical shifts from one another, which is consistent with
the chiral centre at C8 causing nearby protons to have slightly diﬀerent chemical
environments (causing them to be labelled Ha and Hb). These were both shown to
be bonded to C5 from a HSQC correlation, combined with the presence of a COSY
correlation between the two protons. The ﬁnal stage to conﬁrm the coupling of the
peptides to PTCDA was to elucidate a HMBC correlation between H5 protons, and
the C3 carbon which comprises the carbonyl of the PBI. The chemical shift of C3 was
separated from the carbonyl groups in the peptide sequence through the observation
of an HMBC correlation from H1 (PBI aromatic proton) to C3. Subsequently, the
link of PBI between the peptide sequence was conﬁrmed due to the presence of
an HMBC correlation between protons Ha and Hb, and C3. Although peptide-PBI
8 is used as an example here, the same analysis was carried out to conﬁrm the
structure of all other peptide-PBI conjugates in the library, with data presented in
the experimental chapter.
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2.4 Summary
In summary, this chapter presents the synthetic protocols employed to synthesise a
variety of peptide-PBI conjugates via the combination of two well established lit-
erature methods. Firstly, the peptide sequences were synthesised using SPPS and
obtained in good purity which allowed them to be used without puriﬁcation. Sub-
sequently, each peptide precursor was tethered to a PBI core via an amine conden-
sation with the PTCDA starting material. By analysing FTIR spectroscopy, mass
spectrometry, and 2-D NMR experiments, the structural identity of the peptide-PBI
conjugates was conﬁrmed. Additionally, this chapter presents the modiﬁcation of
peptide sequences by exploiting the stepwise assembly of SPPS, in order to allow
investigations as to the inﬂuence the peptide segment has on the self-assembly of the
PBI core. This elucidation is to be achieved by comparing the nature of aggregation
upon; inclusion of a section capable of forming H-bonds, reducing the number of
ionisable groups on the peptide, and increasing the steric hindrance close to the PBI
core.
25
Chapter 3
Spectroscopic probes of
peptide-PBI aggregation
3.1 Introduction
An interesting challenge of supramolecular and materials chemistry is to design
organic semiconductors for use as building blocks that can self-assemble to form
elaborate superstructures. Often these superstructures are desired because they
provide optical and electronic properties not observed by individual units, for exam-
ple eﬃcient energy transfer along a π-stacked aggregate.73 This is achieved via the
electronic coupling between transition dipoles or via eﬀective overlap of π-orbitals.74
This work exploits the optical and electronic properties of PBIs in order to monitor
the local electronic environment of PBI molecules. The optical properties of pery-
lene are attributed to the large π-conjugated system (i.e., ﬁve fused aromatic rings)
present in these molecules. Through examining the perturbation of spectroscopic
signatures, the application of weakly coupled H- (and J-) aggregate theory makes op-
tical spectroscopy an excellent probe of the nature of perylene assembly.19,75,76 The
result is that optical spectroscopic signatures can be used to identify the presence of
aggregates and determine the geometric conﬁguration of neighbouring chromophores
in an aggregate.
This chapter is concerned with exploiting solvent and pH dependent aggregation of
peptide-PBI conjugates in order to demonstrate the ability to elucidate the type
and extent of aggregation using optical absorption and ﬂuorescence spectroscopy.
Spectroscopic signatures of peptide-PBI 6 are highlighted as clear examples. Subse-
quent work in this chapter investigates the inﬂuence the peptide tethered to a PBI
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core has on the assembly process. This is achieved by carrying out various spectro-
scopic measurements as a function of peptide design through the incorporation of
an H-bonding region (peptide-PBI 7 and 8), reduction in the number of ionisable
groups (peptide-PBI 9), and inclusion of sterically bulky groups near the PBI core
(peptide-PBI 10). The results demonstrate that diﬀerent modes of aggregation are
induced by the peptide sequence, with signiﬁcant inﬂuence from the electrostatic
repulsions between glutamic acid residues.
3.2 Spectroscopic perturbations observed in PBI
core interactions
Due to a hydrophilic peptide sequence being tethered symmetrically to a hydropho-
bic PBI core, there is diverse functionality present within each peptide-PBI con-
jugate. This yields a chromophore that has signiﬁcant amphiphilic character due
to the diverse solvation demands. It has been demonstrated in the literature that
solvent selectivity can strongly eﬀect self–assembly kinetics, as well as nanostruc-
ture assemblies, of amphiphilic PBI derivatives.26,32 This section demonstrates the
solvent dependence of peptide-PBI conjugate aggregation, with a signiﬁcant focus
on elucidating the nature of aggregates using absorption spectroscopy through the
application of the exciton model. Throughout this section, peptide-PBI 6 (((Glu)3-
Gly)2-PBI) is employed as an example, due to its short peptide sequence being the
simplest design.
3.2.1 Promoting monomers vs. semi-crystalline aggregates
To elucidate the inﬂuence solvent has on tuning the self-assembly of peptide-PBI
conjugates, the spectral characteristics in diﬀerent solvents were compared to known
monomer and aggregate PBI signals. Figure 3.1 shows absorption and emission spec-
tra of peptide-PBI 6 in dimethylsulfoxide (DMSO), acetonitrile (MeCN), and in the
solid state. Also included is the absorption spectrum of dilute alkyl-PBI 11 in chlo-
roform as reference of PBI monomers in solution, as reported in the literature.23
These data illustrates the presence of isolated PBI chromophores of peptide-PBI 6
in DMSO due to a resolved monomer vibronic progression and strong photolumines-
cence. In contrast, the spectrum in MeCN exhibits pronounced spectral broadening
comparable to the absorption in the solid state. This indicates eﬃcient π-π electronic
overlap between PBI cores in MeCN, and aggregation.
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Figure 3.1 Normalised absorption spectra of peptide-PBI 6 (3.0 × 10−6 m) in
DMSO, MeCN and in the solid state. Also included is the absorption spectrum of
dilute alkyl-PBI 11 (2.0× 10−6 m) as a PBI monomer reference. Additionally the
emission spectra in DMSO and the solid state are presented.
Absorption features of isolated PBI chromophores are evident by pronounced vi-
bronic peaks in the range of 450-525 nm, and a shoulder at 425 nm, as depicted by
alkyl-PBI 11 in chloroform. These peaks correspond to the 0-0, 0-1, 0-2, and 0-3
electronic transitions, with the vibronic progression A0−0 > A0−1 > A0−2. Separation
of these peaks is approximately 1400 cm−1, caused by the main vibrational mode
coupled to an electronic excitation in perylene being the C=C stretch. Monomer
emission depicts the same peak structure in a mirror image of the absorption and
has high intensity, due to perylene having a near unity ﬂuorescence quantum yield.77
The similarity of the absorption and emission spectra of peptide-PBI 6 in the po-
lar aprotic solvent DMSO to that of alkyl-PBI 11 illustrates the predominance of
monomers in DMSO solution. These results show that DMSO is able to solvate
both the peptide component and the π-face of the PBI core, producing isolated
chromophores in solution. On this basis, DMSO is considered a ‘good’ solvent for
peptide-PBI 6.
When peptide-PBI 6 is dispersed in the polar aprotic solvent MeCN, a new absorp-
tion band emerges around 565 nm, and the electronic transitions to higher energy
levels (0-1 and 0-2) are enhanced in comparison to the 0-0 transition. This pro-
nounced spectral broadening is reminiscent of spectra found in liquid crystalline
phases of PBI derivatives,78–80 and therefore indicates long range order with many
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chromophores contributing to the formation of an exciton band. It is concluded
that MeCN can be considered a poor solvent for peptide-PBI 6, based on the strong
perturbations from the monomer spectrum, indicating the formation of strongly
coupled PBI cores and aggregation.
The broad spectrum observed being related to strong π-π electronic overlap is also
supported by the same perturbation being observed for peptide-PBI 6 in the solid
state, in which the lack of solvent forces signiﬁcant aggregation. The eﬃcient π-π
interactions occurring in the solid state is evidenced from the dramatic photolumi-
nescence quenching which is observed in the emission spectrum. Emission from this
thin ﬁlm provides a low intensity band (note spectra in Figure 3.1 are normalised)
which lacks vibronic structure (i.e., is not a mirror image of absorption) and is
red-shifted from 535 nm (for monomer emission) to approximately 675 nm. This
weakly emissive state is attributed to the emission from excimer states formed be-
tween neighbouring PBI cores upon photoexcitation. This assignment is supported
by comparison to model cyclophane-PBI derivatives which form permanent aggre-
gates due to two PBI cores being forced into close proximity by covalently bound
imide substituents.81 This causes strong π-π electronic overlap of PBI cores, thereby
allowing excimer emission to be characterised.
Based on the conclusion that peptide-PBI 6 forms semicrystalline aggregates in
MeCN, it would be expected that emission from these aggregates (data not shown)
would display excimer emission. Although there is substantial photoluminescence
quenching from these aggregates, the emission spectrum obtained resembles that
observed in DMSO in structure and wavelength position, indicating emission from
a weakly coupled chromophore. This appears to provide a conﬂicting result for
absorption and emission spectra. However, due to the weak emission intensity ob-
served from a excimer, it is concluded that a small population of poorly coupled
chromophores would signiﬁcantly hinder the resolution of this emission. The use of
a spectroﬂuorimeter with increased red sensitivity is expected to allow the excimer
emission to be resolved. However, such an instrument was not available at the time
of this study and this investigation was unable to be carried out.
3.2.2 Combination of PBI spectral signatures through sol-
vent tuning
The results discussed in the previous section indicate that self-assembly of peptide-
PBI 6 is solvent dependent, as two polar aprotic solvents (DMSO and MeCN) are
able to induce diﬀerent molecular interactions. To further explore this, a solvent
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series was chosen in which the solubility of the peptide sequence was reduced by
varying the H-bonding ability of the solvent. Figure 3.2 displays the spectra of
peptide-PBI 6 in methanol (MeOH), ethanol (EtOH) and isopropanol (IPA). Upon
increasing the size of the alkyl chain present on the alcohol, there is a reduction in
vibronic structure and concurrently a broadening of the spectrum at longer wave-
lengths. These spectral features are a combination of monomer and aggregate sig-
natures, illustrating that when the peptide segment is exposed to a poor solvent,
aggregation is induced between molecules PBI, causing π-π interactions.
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Figure 3.2 Absorption spectra of peptide-PBI 6 (3.0×10−6 m) in MeOH, EtOH,
and IPA. Also included is the absorption spectrum in DMSO and MeCN for com-
parison. All spectra are normalised at λmax.
The series of alcohols were selected to probe the eﬀects of peptide solubility, based
on their decreasing ability to form H-bonds with increasing alkyl chain size.82 A
reduction in H-bonding ability is expected to bring about less favourable interac-
tions between the peptide sequence and the solvent, thus lowering peptide solubility
(i.e., peptide solubility is expected to follow MeOH > EtOH > IPA). The spec-
trum of peptide-PBI 6 in MeOH exhibits vibronic progression which reﬂects that of
monomers, but with an increased absorption at longer wavelengths. Comparing this
spectrum to that in EtOH shows an increased amount of spectral broadening, which
is increased further in IPA. The appearance of monomeric vibronic progression and
a concurrent broadening results from a linear combination of monomer and tightly
bound aggregate signatures comprising the absorption spectrum, as evidenced upon
comparison with the signatures in DMSO and MeCN.
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In MeOH, the balance of solubility requirements are expected to result in favourable
interactions with the peptide, and moderately favourable interactions with the PBI
core. This is due to MeOH having good H-bonding ability, but also nonpolar char-
acter to solubilise the PBI core. The spectral features of MeOH show that there is
a signiﬁcant population of monomers in solution, and a fraction of tightly coupled
aggregates contributing to the spectral broadening. From these observations it is
concluded that aggregation of the peptide-PBI conjugate is driven by the combi-
nation of π-π, and solvophobic interactions, with a large number of chromophores
being solvated.
On this basis, one would expect the spectrum in EtOH to exhibit more monomeric
features than MeOH, based on the expectation that the longer alkyl chain is able
to provide better solubility to the PBI core. However, the broad spectrum obtained
does not support this conclusion, indicating that there is a greater drive for aggrega-
tion in EtOH. This can be rationalised through the reduced solubility of the peptide
sequence on peptide-PBI 6 molecules having less favourable interactions with EtOH
than MeOH. This conclusion is supported by the large spectral broadening observed
in IPA. The largest alkyl group investigated results in the poorest solvent for the
peptide segment, but has good hydrocarbon properties to aid in the solubility of
PBI cores. The solvation of π-faces on PBI cores are overwhelmed by the weak
H-bonding propensity for the peptides, causing the molecules to undergo aggrega-
tion. To this end, the spectrum of peptide-PBI 6 in IPA closely resembles that in
MeCN and indicates a large presence of tightly bound aggregates in solution, with
the contribution of monomer signatures being small.
The combination of these results show that a linear combination of monomer and
semi-crystalline aggregate can be obtained by tuning the favourability of solvent
interactions. When the peptide sequence tethered to the PBI core is exposed to a
poor solvent, the aggregation is promoted in order to reduce unfavourable solvent-
peptide interactions and a strong contribution of strongly coupled aggregates is
observed in the absorption spectrum. If the solvent is able to accommodate the
solvation demands of both the peptide and the PBI core, then aggregation is driven
by π-π interactions, with the resulting spectrum having large monomer signature
contributions. These results demonstrate the ability to tune peptide-PBI aggrega-
tion through solvent tuning. This principle is explored in greater detail in Chapter
4 through the variation of solvent compositions.
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3.2.3 Exciton model applied to aggregates in water
The driving force of self-assembly of amphiphilic molecules in water typically in-
volves the balance between various intermolecular interactions, for example; π-π,
hydrophobic, H-bonding, and electrostatic interactions.83 The ﬁrst three forces gen-
erally promote aggregation, whilst interactions between ionised groups can either
disrupt (electrostatic repulsion) or induce (electrostatic attraction) aggregation of
molecular building blocks in solution. A corollary of tuning the favourability of in-
teractions between solvent and peptide-PBI conjugates is to select a solvent that is
good for the peptide, but poor for the PBI core, for example water.
Figure 3.3 shows the absorption spectrum of peptide-PBI 6 in distilled water, illus-
trating the formation of aggregates in solution due to absorption at longer wave-
lengths.13 Also observed is a redistribution of the vibronic progression (compared
to the monomer progression) to yield a reversal in peak intensities, i.e., A0−1 >
A0−0. The comparison of the spectrum of peptide-PBI 6 in water with MeCN and
DMSO illustrates that there is some contributions of monomer and semicrystalline
signatures. However, no linear combination of these two signatures can account for
the redistribution of vibronic intensity, indicating that the nature of the aggregate
is signiﬁcantly diﬀerent from the semicrystalline state observed in MeCN. The re-
distribution of oscillator strength can be explained by application of the molecular
exciton model for dimer aggregates.84,85
This model applies a point-dipole approximation and predicts that coupling of tran-
sition dipole moments creates two new exciton states due to eﬀective π-π electronic
coupling. This model treats the dye aggregates as a dimer and can be applied to ex-
plain the characteristic spectral features which occur for H- and J-aggregates. Both
these aggregates are cofacial with parallel transition moments, but have diﬀerent
types of geometric distortions between the chromophores. Two chromophores in a
J-aggregate conﬁguration have a translation oﬀset, whilst an H-aggregate conﬁgu-
ration involve cofacially stacked chromophores with no slip.
An energy diagram for these two types of aggregates is shown in Figure 3.4 and
illustrates the optical transitions of these cofacial aggregates. For an H-aggregate,
the transition from the ground state to the upper exciton state is fully allowed, with
the dimer possessing an overall dipole moment. In contrast, the transition from the
ground state to the lower exciton state is forbidden due to the transition dipole of
each chromophore being out of phase, causing no net dipole moment for the dimer.
The exact opposite argument is used to explain the allowed/forbidden transitions
in a J-aggregate.
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Figure 3.3 Absorption spectra of peptide-PBI 6 (3.0×10−6 m) in distilled water.
Also included is the absorption spectrum in DMSO and MeCN for comparison. All
spectra are normalised at λmax.
The arguments applied to the transitions from the ground state to a particular ex-
citon state being allowed or forbidden in Figure 3.4 are based on strongly coupled
H- and J- aggregates. In other words, for the H-aggregate reasoning, the transition
dipoles of each chromophore are considered perfectly parallel to one another. Whilst
in a J-aggregate, the transition dipoles are still parallel but are in phase with one
another. These assumptions are useful for conveying the concepts of the exciton
model, however these assumptions can break down when applied to weakly coupled
aggregates (i.e., not perfectly parallel, or not perfectly in phase). In such situations,
a more rigorous application of the exciton model needs to be applied. The deriva-
tion and detailed description of the exciton model is omitted here, but the reader
can ﬁnd such details in the literature.84,86 One important prediction obtained from
the exciton model is that the exciton splitting energy (2ǫ) that results from two
interacting molecules is dependent on the relative orientation and distance between
the chromophores. The exciton splitting energy, ǫ is given by equation 3.1:20
∆ǫ = 2ǫ =
2|~µ|2
4πǫ0r3
(cosϕ− 3cos2θ) (3.1)
where ~µ is the transition dipole moment of the monomer, ǫ0 the permittivity of a vac-
uum, r the distance between the centres of the two interacting molecules, and ϕ and
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Figure 3.4 Energy diagram for aggregated dimers with coplanar transition
dipoles, depicting the allowed and forbidden transitions to H- and J- aggregates
based on the dipole phase relations.
θ are the rotational and slip oﬀsets, respectively, between adjacent chromophores.
This clearly shows the dependence the exciton splitting energy has on the relative
orientation (and distance) of the interacting chromophores. An energy diagram of
the exciton splitting for an H-aggregate is shown in Figure 3.5, illustrating the en-
ergetic splitting with constant slip angle (θ = 90◦) as a function of rotational oﬀset,
ϕ. This shows that although the transition to the lower exciton state is usually
forbidden in an H-aggregate, if there is a rotational displacement between cofacial
chromophores (i.e., a weakly coupled H-aggregate), the transition can gain oscil-
lator strength by coupling to a vibrational mode (i.e., the 0–1 becomes allowed).
However, the zero vibration transition to the lower exciton state is forbidden, as it
cannot gain oscillator strength by coupling to a vibration.19
Based on the predictions depicted in the energy diagram, the absorption spectrum
of peptide-PBI 6 in water is indicative of weakly coupled H-aggregates being formed,
due to the redistribution of oscillator strength to higher energy, and a relative weak-
ening of the 0–0 vibronic peak. This type of aggregate is rationalised in distilled
water based on the minimization of hydrophobic interactions in this cofacial ar-
rangement, whilst electrostatic repulsions between ionised glutamic acid residues
promote rotational displacement (pKa glutamic acid side chain in water is approx-
imately 4.2).87 Although these repulsive forces favour the formation of monomers
in solution, the large hydrophobic demands of the PBI core means these interaction
forces are balanced in a twisted aggregate. Chapter 5 will further elucidate the
eﬀects electrostatic repulsion imparts on peptide-PBI aggregates.
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Figure 3.5 Energy diagram for aggregated dimers with transition dipoles with
a rotational displacement (ϕ), illustrating the eﬀects of twisting between adjacent
chromophores on the transition energy and exciton splitting, ǫ. In this depiction,
the translation component of equation 3.1 is constant, i.e., θ = 90◦. Box on the
right depicts the transition to the lower exciton state gaining oscillator strength by
coupling to a vibrational mode.
The exciton model has therefore allowed the elucidation of the extent of electronic
coupling between PBI chromophores between peptide-PBI conjugates. The conclu-
sion that there is a weakly coupled H-aggregate in solution is supported by similar
spectroscopic signatures reported in the literature for model covalently bridged PBI
dimers.24,88,89 These model PBI dimers follow the predictions made by the exciton
model, showing that when adjacent chromophores have a limited twist there is a
relative weakening of 0–0 peaks, with redistribution to the 0–1 band. Additionally,
these studies show that by increasing the twisting between chromophores, through
the incorporation of sterically bulky substituents, the eﬀective coupling is decreased
and the 0–0 transition recovers. Additionally, the exciton model indicates that the
ratio of the 0-1 vibronic peak in relation to the 0–0 vibronic peak allows for insight
into the extent of electronic coupling between adjacent PBI cores. To this end, the
vibronic peak ratio of peptide-PBI 6 in distilled water was compared to the vibronic
peak ratio observed in DMSO, summarised inTable 3.1.
Table 3.1 Vibronic peak ratios of peptide-PBI 6 in water and DMSO showing the
change upon H-aggregate formation.
Solvent Vibronic Peak Ratio (A0−1
A0−0
) Nature of molecules
Distilled water 1.38 Weakly coupled H-aggregate
DMSO 0.61 Isolated chromophores
Firstly, it is observed that the vibronic ratio of 0.6 for peptide-PBI 6 in DMSO
reﬂects that of isolated chromophores in solution. Therefore, any ratio higher than
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this can be considered to have some degree of cofacial pairing between chromophore
transition dipoles. Peptide-PBI 6 in distilled water shows a signiﬁcant increase in
the vibronic peak ratio, consistent with cofacial interactions between chromophores.
Upon aggregation in distilled water, the electrostatic repulsions between ionised
glutamic acid residues on each peptide-PBI conjugate are in close proximity to their
respective PBI cores, due to the short peptide sequence. In order for the aggregate
to accommodate this, there is an increased twist between adjacent chromophores.
However, this alone would cause a reduced excitonic coupling as the aggregates
would become rotationally displaced and appear close to a monomer ratio. On the
other hand, twisting of neighbouring molecules would expose PBI cores to water,
which is a highly unfavourable interaction. Therefore, the twisting of an H-aggregate
in peptide-PBI chromophores is a balance of these two forces acting on the system.
This geometric information that we are able to infer from the optical signatures
cannot easily be obtained by other experimental methods, such as nuclear magnetic
resonance (NMR) spectroscopy or X-ray scattering techniques.
3.2.4 Tuning aggregates through pH changes
To investigate the extent of modulation from electrostatic repulsion, the pH of the
solution is changed in order to observe the pH sensitivity of aggregates. Figure 3.6
shows the absorption and emission spectra of peptide-PBI 6 in distilled water (ap-
proximately pH = 7) and dilute HCl (approximately pH = 3) at acidic pH. At low
pH values (i.e., pH . 4) the carboxylic acid on the glutamic acid side chain is pro-
tonated, based on the pKa in water (approximately 4.2). When the pH value is
decreased (to acidic), there is a loss of vibronic peak resolution and spectral broad-
ening in the absorption spectrum, while signiﬁcant photoluminescence quenching is
observed in the emission spectrum. These spectral changes indicate that when the
glutamic acid residues are protonated, there is a increase in eﬀective π-π electronic
overlap of adjacent chromophores. Furthermore, at acidic pH the H-aggregate vi-
bronic peaks are diminished, resulting in a signature reminiscent of semicrystalline
aggregates in solution, similar to that observed in MeCN.
The lack of ionised glutamic acid residues reduces the electrostatic repulsions be-
tween peptide segments, hence the removal of the dominant driving force for cofacial
twisting of the H-aggregate. A result of this is that the twisting between adjacent
PBI chromophores is diminished, thus adjacent chromophores obtain eﬃcient π-
orbital overlap. This is apparent in the absorption spectrum of peptide-PBI 6 in
acidic solution resembling similar spectroscopic features of peptide-PBI 6 in MeCN,
indicating semicrystalline aggregates.
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Figure 3.6 Absorption (solid line) and emission (dashed line) of peptide-PBI 6
(3.0 × 10−6 m) in neutral (distilled water) and acidic (1 × 10−3 m HCl) solution.
Absorption spectra are normalised to λmax, the excitation wavelength for emission
was 500 nm. Also depicted is a schematic illustrating the formation of tightly coupled
aggregates at acidic pH due to the lack of electrostatic repulsion between glutamic
acid residues.
Supporting evidence for stronger interactions occurring in acidic solution, com-
pared to neutral pH, is obtained from the emission spectra. The photoluminescence
quenching which occurs in acidic solution is indicative of eﬀective π-π electronic
overlap of neighbouring PBI cores. Both neutral and acidic solution have emission
spectral signatures of monomer emission. However, both these solutions see a dra-
matically reduced emission intensity compared to that of known monomer emission
(i.e., alkyl-PBI 11, not shown). Such emission may be expected from a weakly cou-
pled H-aggregate, i.e., in distilled water, however tightly bound aggregates would be
expected to produce excimer emission (see above). This monomer-like emission sig-
nature can be rationalised through the apparent solubility of peptide-PBI 6 in acidic
solution. Upon dispersion of peptide-PBI 6 in acidic solution, the loss of ionised
glutamic acid residues will reduce the solubility in water, increasing the impetus
for aggregation. However, the presence of monomer emission indicates the presence
of some monomers in solution, but likely not very many due to the hydrophobicity
of the molecules. Nevertheless, emission from the monomers hinders resolution of
excimer emission due to its weakly emissive nature.
To further investigate the eﬀect changing the pH can impart on the self-assembly
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in solution, cryogenic scanning electron microscopy (cryo-SEM) was performed in
neutral and acidic solutions. Figure 3.7 presents cryo-SEM images of peptide-PBI 6
at neutral pH (distilled water). These images show the presence of well deﬁned self-
assembled nanoﬁbres present in solution, on a micrometer length scale dimension.
These ﬁbres form an elaborate branched network with the thickest sections having
a width of approximately 300 nm. Upon splitting into a branched ﬁbre, the width is
reduced to less than 100 nm. The absorption spectrum of peptide-PBI 6 in distilled
water indicates the presence of weakly coupled H-aggregates. Combined with the
cryo-SEM images, it can be concluded that these H-aggregates are self-assembled
into a ﬁbre network with long range order.
Figure 3.8 shows the cryo-SEM images for peptide-PBI 6 in acidic solution. The
preparation of acidic solution cryo-SEM samples was identical (e.g. same volume,
concentration, and etching procedure) to that used for the collected neutral solution
images. This allows for direct comparison of the samples as only one variable has
been changed, the pH value. The images obtained in acidic solution show the com-
plete absence of ﬁbre structures, and instead disordered, clump-like aggregates are
present. There appears to be no long range order in this system, due to no obvious
interaction occurring between aggregates in the cryo-SEM images.
The absence of electrostatic repulsion between glutamic acid residues, has been
shown in the absorption spectrum to allow stronger electronic overlap between
PBI cores due to spectral broadening. Furthermore, the inherent solubility of the
molecule is also aﬀected because removing the number of ionised groups will increase
the dominance of the hydrophobic force. Clusters of strongly coupled aggregates
present at acidic pH can be rationalised based on the combination of a reduced
disruption of aggregation, and the minimisation of unfavourable hydrophobic inter-
actions in the solvent.
The appearance of branched ﬁbre motifs of PBI derivatives have recently been re-
ported by Rybtchinski et al. .90,91 The ﬁbres formed in such studies were formed
through tuning the solvent environment to exploit the combination of hydropho-
bic interactions and intermolecular H-bonding. This resulted in PBI derivatives
forming a three-dimensional network of bundled ﬁbres, which were able to trap sol-
vent molecules to form an organogel. The authors were able to investigate how the
structures were ordered by performing cryogenic transmission electron microscopy
(cryo-TEM). This elucidation is possible through cryo-TEM because dark-regions
represent a tightly stacked conjugate system, possessing high electron density, whilst
lighter-contrast areas represent a solvated hydrophilic environment.92
38
Figure 3.7 Cryo-SEM images of peptide-PBI 6 (0.26 wt%) in distilled water (pH
≈ 7) showing the extended network of branched ﬁbres formed through the self-
assembly of weakly coupled H-aggregates in solution.
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Figure 3.8 Cryo-SEM images of peptide-PBI 6 (0.26 wt%) in dilute HCl (1 ×
10−3 m, pH ≈ 3) showing the lack of long range order present in the tightly bound,
semicrystalline aggregates in solution.
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Unfortunately, no cryo-TEM capabilities were available throughout this work so no
further investigation of peptide-PBI 6 ﬁbres could be obtained. However, cryo-TEM
images of the peptide-PBI conjugate library are currently being investigated through
collaboration with the Rybtchinski group, but will not be obtained in time to be
included in this work. Cryo-TEM images should aid in determining the alignment
of peptide-PBI conjugates (e.g. molecular alignment down the length, or across the
width of the ﬁbre). Furthermore, investigation as to what causes branching of the
ﬁbres could provide insight into the non-covalent intermolecular interactions that
contribute to the directional assembly.
3.3 Effects of peptide sequence on aggregation
The previous section demonstrated the use of optical absorption and emission spec-
troscopy to elucidate the type and extent of aggregation in solution, via probing
the π-π electronic coupling of PBI chromophores. In order to investigate what ef-
fect the peptide sequence imparts on the aggregation, spectroscopic measurements
were carried out for a range of peptide-PBI conjugates depicted in Figure 3.9. This
section explores the eﬀects of incorporating certain design features into the peptide
sequence, namely; the inclusion of an H-bonding region (peptide-PBI 7 and 8), re-
ducing the number of ionisable groups (peptide-PBI 9), and introducing sterically
bulky amino acid residues (peptide-PBI 10).
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Peptide-PBI Conjugates
Figure 3.9 Key peptide-PBI conjugates illustrating the various design features
employed to elucidate the inﬂuence the peptide segment has on the self-assembly.
3.3.1 Incorporation of an H-bonding section
In order to probe what eﬀects H-bonding can have on the assembly of peptide-
PBI conjugates, the peptide segment was extended to include three amino acid
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residues capable of forming intermolecular H-bonds, namely glycine (peptide-PBI 7)
or alanine (peptide-PBI 8). Figure 3.10 shows the absorption spectra of peptide-PBI
8 in DMSO, acidic and neutral water, and MeCN. These results show the appearance
of a monomer vibronic progression in DMSO, a broad, featureless absorption in
MeCN and acidic water, and a characteristic redistribution of oscillator strength
to yield an inverted vibronic progression in neutral water. The inset displays the
circular dichroism (CD) spectra in DMSO and neutral water, showing the absence
of spectral features in DMSO and the appearance of a bisignate signature in neutral
water. These results demonstrate that the solvent dependent aggregation remains
in peptide–PBI conjugates upon the inclusion of a H-bonding section.
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Figure 3.10 Absorption spectra of peptide-PBI 8 (3.0×10−6 m) in DMSO, acidic
H2O, neutral H2O and MeCN. Inset : CD peptide-PBI 8 in DMSO and neutral H2O,
showing the formation of chiral aggregates in neutral H2O induced through the chiral
peptide tethered to the PBI core.
The spectral signatures of peptide-PBI 8 in DMSO reﬂect isolated chromophores
in solution, due to the appearance of the characteristic vibronic progression, which
was also observed in the absence of a region capable of H-bonding (e.g. peptide-PBI
6 in neutral water). Therefore, DMSO remains a good solvent for the peptide-PBI
conjugate as it satisﬁes all solvation requirements of the molecule. The spectra
of peptide-PBI 8 in MeCN and acidic water are very similar to those observed for
peptide-PBI 6 in the same solvents which were comparable to the spectral signatures
observed in the solid state. This indicates that the region potentially capable of H-
bonding does not hinder the formation of semicrystalline aggregates in MeCN or
acidic water. Note, the diﬀerence in extinction coeﬃcient observed between acidic
water and MeCN for peptide-PBI 8 is likely caused by the reduced solubility in
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these solvents, which can result in a precipitation during the experiment producing
changes in the concentration of solute in solution.
Interestingly, peptide precursor 3 (NH2–Gly–Ala–Ala–Ala–Glu–Glu–Glu) which is
the parent peptide of peptide-PBI 8, formed a self-supporting gel in MeCN. This was
evident through the ‘inversion-of-the-vial’ method which has been utilised in peptide
amphiphile gelation studies.93 The formation of a self-supporting gel is typically
caused by the formation of a network of ﬁbres, through extensive intermolecular
interactions, which traps solvent molecules.60,61 This organogelation of peptide 3 in
MeCN suggests that the tendency of the peptide to self-assemble into ﬁbres through
the formation of H-bonds, may drive the formation of the extended semicrystalline
aggregates of peptide-PBI 8 in MeCN.
An interesting observation upon the inclusion of a H-bonding region is obtained
in the CD spectrum of peptide-PBI 8, shown in Figure 3.10. This shows the ap-
pearance of a bisignate signature which is indicative of a chiral aggregate in water.
Furthermore, this feature appears in the region of PBI absorption which is indicative
of chiral exciton coupling between PBI chromophores.94 From this result, it is de-
termined that the inclusion of chiral amino acid residues (i.e., alanine) close to the
PBI core are able to induce the formation of a chiral aggregates in distilled water.
This is supported by the fact that no exciton couplet signature is observed from the
isolated chromophores (in DMSO), or for peptide-PBI 7 (containing achiral glycine
residues) in any solvent (data not shown). Additionally, the chromophores in water
are arranged in a right-handed helix, based on the sign of the CD-couplet (negative
to positive with increasing wavelength).33
Chiral aggregates belong to an interesting class of PBI-aggregates, which are receiv-
ing considerable attention in the literature,33,34,95 due to their promise for application
in novel optoelectronic applications.96,97 Although CD signatures presented in this
work demonstrate the formation of these chiral structures, this avenue requires fur-
ther investigation which falls outside the scope of this work. For example, only the
naturally occurring l-alanine residue was employed in this investigation. In order
to conﬁrm that this residue imparts the chirality, d-alanine should be incorporated,
which should yield the opposite handedness of the aggregate helix (i.e., the inverted
CD-couplet).
We now turn to the absorption spectrum of peptide-PBI 8 in water, which exhibits
a redistribution of vibronic peak intensity to higher energy (i.e., weakening of the
0-0 transition compared to the 0-1 transition). These data is consistent with the
formation of a weakly coupled cofacial H-aggregate in solution, determined via the
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application of the exciton model (see above). An important result of this H-aggregate
conﬁguration is that important information can be gained from comparing vibronic
peak ratios of diﬀerent compounds (i.e., the relative rotational displacement between
chromophores). To interrogate the eﬀect the incorporation of an H-bonding segment
has on self-assembly, the vibronic peak ratio (A0-1
A0-0
) for peptide-PBI 7 and 8 were
compared to peptide-PBI 6 in distilled water. The vibronic ratios of these conjugates
are summarised in Table 3.2 and indicate there is a tuning of twisting between
chromophores upon H-bonding amino acid incorporation.
Table 3.2 Vibronic peak ratios of peptide-PBI 6, 7 and 8 in H2O and alkyl-PBI
11 in chloroform as monomer reference.
PBI derivative Vibronic Peak Ratio (A0−1
A0−0
)
(Glu−Glu−Glu−Gly)
2
– PBI (6) 1.38
(Glu−Glu−Glu−Gly−Gly−Gly−Gly)
2
– PBI (7) 1.22
(Glu−Glu−Glu−Ala−Ala−Ala−Gly)
2
– PBI (8) 0.86
(C
12
H
25
)
2
– PBI (11) 0.61
Recall that for peptide-PBI 6 the large vibronic peak ratio was rationalised through
the balance of electrostatic repulsion of the short peptide, and unfavourable solva-
tion of the hydrophobic PBI core. Comparison of the resulting vibronic peak ratio
to the two peptide–PBI conjugates which contain H-bonding amino acids shows a
decreased magnitude of the ratio. This indicates a decreased amount of π-π inter-
actions of neighbouring PBI cores, implying a greater twisting of the H-aggregate.
One immediate inference obtained from this comparison is that there is no evidence
of H-bonding being able to ‘knit together’ the PBI chromophores. Formation of
H-bonds between molecules would be expected to reduce the twisting of aggregates,
due to the added driving force of assembly. Due to the inverse alteration being ob-
served, the potential formation of H-bonds is likely overwhelmed by the electrostatic
repulsion between ionised glutamic acid residues. The increased twist observed upon
the inclusion of an H-bonding region can be rationalised by the extended length of
the peptide which generates more hydrophilic character tethered to the PBI core.
The presence of hydrophilic amino acid residues is therefore likely to aid in solva-
tion close to the aromatic core, therefore the balance of forces causing the twist is
dominated by electrostatic repulsion.
Although we do not ﬁnd evidence that H-bonding drives twisted aggregation, we do
observe a diﬀerence between the two types of H-bonding amino acids incorporated.
This diﬀerence can be explained through considering the side chain present in these
amino acid residues (e.g. either an H, or a CH3 group). The diﬀerence in side chain
can generate diﬀerent eﬀects in two ways. Firstly, due to glycine residues having
a slightly higher propensity to form β-sheets than alanine residues,98 the presence
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of glycine amino acids in the H-bonding section could allow the formation of some
H-bonds, which are formed stronger than the alanine derivative. This could cause a
slight reduction in twisting between adjacent chromophores. Secondly, the greater
degree of twisting observed with peptide-PBI 8 over peptide-PBI 7 could simply be
explained by the additional steric demands of the CH3 group in alanine residues.
The exact reason is unable to be determined and is likely to be a combination of
these factors.
3.3.2 Reducing the number of ionisable groups
The appearance of weakly coupled H-aggregates being formed in water for peptide–
PBI conjugates, indicate that electrostatic repulsion between ionised glutamic acid
residues inﬂuences the aggregation signiﬁcantly in water. In order to investigate
the role electrostatics have in imparting a twist between chromophores within ag-
gregates, the eﬀects observed upon reducing the number of ionisable groups on
the peptide segment was studied. This was achieved by the synthesising peptide-
precursor 4 (Glu–Ala–Ala–Ala–Gly–NH2) containing only one glutamic acid residue,
instead of three used previously in this work.
Figure 3.11 shows the absorption spectrum of peptide-PBI 9 ((Glu–Ala–Ala–Ala–
Gly)2–PBI) and peptide–PBI 8 in distilled water. These data illustrates that upon
reducing the electrostatic repulsion between peptide sequences there is a substantial
weakening of the 0-0 vibronic transition. These spectral features are consistent
with H-aggregate formation, allowing important information to be obtained on the
twisting between neighbouring chromophores from the vibronic peak ratio.
Recall that the twist present in H-aggregates of peptide–PBI conjugates is a result
of a balance between hydrophobicity of the PBI core, and electrostatic repulsion
between glutamic acid residues. In peptide-PBI 9 the electrostatic repulsion between
peptide segments is reduced, based on the reduction in the number of ionisable
groups from three to one (per peptide sequence). Therefore, any eﬀect this has on
the nature of the aggregate can be deduced through the analysis of the vibronic
peak ratio.
Table 3.3 shows the vibronic peak ratio for these spectra and shows that there is
a greater vibronic ratio of peptide-PBI 9 than peptide-PBI 8. The increase in
vibronic ratio observed is rationalised by the reduced electrostatic repulsion that
drives rotational distortion. This eﬀectively pushes the balance of forces in favour
of the hydrophobic eﬀect, in which a lower degree of twist in a cofacial conﬁguration
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Figure 3.11 Absorption spectra of peptide-PBI 8 and 9 (3.0×10−6 m) in distilled
water.
provides a minimisation of hydrophobic interactions in water. These results demon-
strate the tuning of the aggregate structure through modulating the electrostatic
repulsions between glutamic acid residues. This approach to controlling the nature
of aggregates in aqueous solution is explored in detail in Chapter 5.
Table 3.3 Vibronic peak ratios of peptide-PBI 8 and 9 in H2O, and 11 in chloro-
form as monomer reference.
PBI derivative Vibronic Peak Ratio (A0−1
A0−0
)
(Glu−Ala−Ala−Ala−Gly)
2
– PBI (9) 1.23
(Glu−Glu−Glu−Ala−Ala−Ala−Gly)
2
– PBI (8) 0.86
(C
12
H
25
)
2
– PBI (11) 0.61
3.3.3 Incorporation of sterically demanding amino acids
The incorporation of a H-bonding sequence into the peptide tethered to the PBI
core indicated that an increased twist between coupled chromophores had some
contribution from accommodating increased steric demand. To explore this con-
cept, leucine amino acids were incorporated into the middle region of the peptide
to obtain peptide-PBI 10 ((Glu-Glu–Glu–Leu–Leu–Leu–Gly)2–PBI). This causes a
relatively bulky group to be in close proximity to the PBI core. Figure 3.12 displays
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the absorption spectrum of peptide-PBI 10 in distilled water, with peptide-PBI
8 included for comparison. The spectrum shows a vibronic progression reﬂecting
that of monomers in solution, and concurrently a absorption band appears at longer
wavelengths. The comparison with a known H-aggregate signature (i.e., that of
peptide-PBI 8) shows a diﬀerent perturbation from the monomer spectrum, indi-
cating a diﬀerent type of aggregate.
J-type stacking
J-type band
Steric 
crowding
H-type stacking
Figure 3.12 Absorption spectra of peptide-PBI 8 and 10 (3.0 × 10−6 m) in
distilled water. Also shown is a schematic demonstrating the relieving of steric
strain close to the PBI core with slipped geometry, i.e., J-aggregate formation.
The spectral data for peptide-PBI 10 is consistent with the formation of a J-
aggregate (i.e., a cofacial aggregate having translational slipping as opposed to
rotational displacements displayed for the other peptide–PBI conjugates). In the
literature, J-aggregates of PBI derivatives are characterised by the concurrent ap-
pearance of a monomer vibronic progression and a broad absorption band appearing
between 620–650 nm.99,100 This comparison with the literature supports the forma-
tion of J-aggregates in peptide-PBI 10, with the J-type band appearing at approx-
imately 615 nm, slightly higher energy than those reported in the literature. The
formation of a J-aggregate conﬁguration can be rationalised through the increase
in steric bulk associated with the iPr group compared to the CH3 group of alanine
(peptide-PBI 8).
Increased steric bulk would cause unfavourable steric crowding close to the PBI core
in an H-aggregate conﬁguration, whereby the aggregate becomes thermodynamically
unstable. In order to accommodate for the steric bulk, the molecular building blocks
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adopt slipped J-aggregate geometry. The formation of J-aggregates through the
minimisation of steric crowding has been reported in other PBI derivatives in the
literature,24 thereby supporting the formation of J-aggregates for peptide-PBI 10.
Similarly, the leucine amino acids possess a signiﬁcant hydrophobic character, which
could also inﬂuence the destabilisation of an H-aggregate geometry. On this basis,
the formation of J-aggregates would be favoured in order to embed the iPr group with
the PBI core in order to minimise unfavourable hydrophobic interactions, similar to
arguments put forward for H-bonding amino acids. The dominant driving force
cannot be elucidated from these data, however these interactions may not be too
diﬀerent, thus a combination of the two is likely to occur.
Although the 615 nm peak appears consistent with J-aggregate formation, there re-
mains ambiguity around its assignment. Uncertainty arises due to the position of the
J-band being at relatively high energy compared to some derivatives in the literature.
Furthermore, the slipped geometry in these types of aggregates generally results in
relatively poor π-π electronic coupling between adjacent chromophores, which in
turn yields high photoluminescence.101 The emission spectrum of peptide-PBI 10
in water (data not shown) exhibits strongly quenched photoluminescence, compa-
rable with the H-aggregates formed with the other peptide-PBI conjugates. These
contradictory observations highlight the need for further investigation to establish
whether the signature observed is a true J-aggregate, or if it relates to a structural
motif of a much larger aggregate related to the aggregates found in MeCN for all
peptide-PBI conjugates.
Unfortunately, such investigations were not carried out in this research due to time
constraints. However, these investigations could be achieved by varying the steric
bulk employed. For example, the comparison of alanine, leucine, and isoleucine
could exhibit a direct trend caused from the increasing steric bulk. Furthermore,
very bulky groups could be employed. For example, phenylalanine or tryptophan
residues would be expected to have a high degree of steric crowding near the PBI
core of a peptide-PBI conjugate. Issues that could arise with interpreting the use of
side chains of a phenyl group derivative relate to the possibility of π-π interactions
with the PBI core, therefore initial investigations are recommended to focus on alkyl
bulk instead.
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3.4 Summary
In summary, this chapter illustrates the solvent, and peptide sequence, dependent
aggregation of peptide-PBI conjugates through the examination of optical absorp-
tion and ﬂuorescence spectroscopic signatures. The perturbations of signatures from
those observed from isolated chromophores demonstrate the ability to probe the ge-
ometric conﬁguration between neighbouring chromophores. Through modulation of
solvent environment it has been shown that monomers (in DMSO), semicrystalline
aggregates (in MeCN) or a combination of these aggregates can be obtained in solu-
tion. Additionally, the application of the exciton model to peptide-PBI conjugates
in water determined that weakly coupled H-aggregates were formed where the elec-
trostatic repulsion between peptide segments strongly modulates the rotational dis-
placements of adjacent chromophores. The inﬂuence of electrostatic repulsion results
in aggregates that can be tuned through change in pH, observed through cryo-SEM
images depicting a branched ﬁbre network in neutral water, but semicrystalline type
aggregates in acidic water. The tuning of peptide-PBI aggregates through solvent-
dependence is investigated in detail in Chapter 4.
Subsequently this chapter investigated the inﬂuence the peptide is able to impart on
the nature of aggregates formed in solution, in particular water. This was achieved
through examining the change in the nature of aggregation as a function of peptide
design. Due to the formation of H-aggregates for all but one peptide–PBI conju-
gate in water, important information is gained through analysing the vibronic peak
ratios. Table 3.4 summarises these ﬁndings by linking the vibronic peak ratio to a
schematic representation of the aggregate in solution. These results illustrate that
the presence of a H-bonding sequence fails to knit together PBI chromophores, and
instead increases the twisting within an H-aggregate. The addition of large steric
bulk close to the PBI core appears to cause J-aggregate geometry to be favoured
in order to reduce steric crowding. Additionally, by reducing the number of ionis-
able groups in the peptide sequence, the inﬂuence of electrostatic repulsion on the
mode of aggregation was elucidated. This aggregation is strongly modulated by
electrostatic repulsions between glutamic acid residues and is investigated in detail
in Chapter 5.
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Table 3.4 Summary of the nature of aggregates in water derived from the vibronic
peak ratios observed.
Peptide-PBI Vibronic Peak Ratio Schematic of
derivative (A0−1
A0−0
) aggregate present
((Glu)3–Gly))2 – PBI (6) 1.38
-
-
-
-
- -
-
-
-
-
-
--
--
-
-
-
((Glu)3–(Gly)3–Gly))2 – PBI (7) 1.22
-
-
-
-
--
-
-
-
-
-
-
- -
-
-
-
-
((Glu)3–(Ala)3–Gly))2 – PBI (8) 0.86
(Glu–(Ala)3–Gly))2 – PBI (9) 1.22
((Glu)3–(Leu)3–Gly))2 – PBI (10) . . .
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Chapter 4
Solvent composition dependent
peptide-PBI aggregation
4.1 Introduction
Precise control of the self-assembly of molecular building blocks is an attractive
approach to obtaining distinct supramolecular structures and is a major challenge
in supramolecular and materials chemistry.102 Design of molecular building blocks
often employ structural features which impart diverse solvation demands, creating
amphiphilic molecules.103 The self-assembly of amphiphilic molecules typically de-
pends on the combination of molecular structure, intermolecular interactions, and
solvent-molecule interactions.83,104–106 Supramolecular assemblies comprised of am-
phiphilic molecules have been shown to be sensitive to changes in solvent polarity.
For example, it has been reported that N -stearoyl-l-glutamic acid forms nanoﬁbres
in chloroform, whilst in a 1:1 mixture of ethanol:water nanodisks are observed.107
This illustrates that by varying solvent compositions, it is possible to tune the ag-
gregation properties of molecular building blocks and change the nanostructure of
aggregates.108
Recently, there has been a growing interest regarding amphiphilic PBI derivatives
in the literature, with numerous examples being reported from various research
groups.26,29,109–111 Bay-unsubstituted PBIs (no substitution on the aromatic core)
typically form columnar stacks due to their strong propensity to align via π-π inter-
actions.112 By varying the solvent compositions, studies have shown that assembly
of PBI derivatives can be tuned to form various nanostructures; including spheres,
wires, belts, and sheets.32 This tuning is achieved by varying the amount of good
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solvent (i.e., solvent promoting monomers) and bad solvent (i.e., solvent promoting
aggregation) that the molecules (or aggregates) are exposed to. Inducing organisa-
tion of functional materials could allow various types of supramolecular structures
with desirable optical and electronic properties, for use in various applications. For
example, the controlled reorganisation of functional materials is of interest as such
systems could be applied to sensor applications.113–115 The principle employed in
this application would be that molecules (or aggregates) undergo reorganisation in
the presence of a particular target analyte, thus allowing optical changes (i.e., in-
creased photoluminescence) to be monitored indicating the presence (or absence) of
the target analyte.116
This chapter investigates the solvent composition dependent aggregation of peptide-
PBI conjugates 8 and 9 (see Figure 4.1) in various solvent compositions. These
peptide-PBI conjugates form hydrophobically driven aggregates in water (due to
the PBI core), whilst the hydrophilic peptide sequence contains two distinct re-
gions, one capable of H-bonding, and another with ionisable glutamic acid residues.
By varying the composition of DMSO-water mixtures we illustrate the ability to
induce formation of H-aggregates from a solution containing isolated chromophores.
Additionally it is demonstrated that by varying the composition of MeCN-water
mixtures there is a reorganisation of strongly coupled aggregates. This reorgani-
sation is determined to be driven by the electrostatic repulsion between glutamic
acid side chains, when there is suﬃcient water to promote the ionisation of glutamic
acid. A possible mechanism for this process was deduced using salt-doped solvent
systems in order to screen the charge formation on ionisable side chains.
NN
O
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O
O
RR
Gly (Ala)3 (Glu)3   : R= OH
Gly (Ala)3 (Glu) : R= OH
8
9
Figure 4.1 Key compounds utilised to investigate solvent composition dependent
aggregation and reorganisation.
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4.2 From monomers to cofacial peptide-PBI ag-
gregates
It has been shown in the literature that solvent selectivity can strongly aﬀect self-
assembly kinetics as well as nanostructure assemblies of PBI derivatives.32 Recall
that DMSO is considered a good solvent for peptide-PBI 8, whilst water is consid-
ered a relatively bad solvent as there is a large amount of cofacial π-π aggregation.
This section is concerned with the solvent induced assembly of peptide-PBI 8 using
mixtures of good and bad solvents, and demonstrates the ability to induce aggrega-
tion of monomers to form extended cofacial aggregates.
In order to investigate the assembly of monomers of peptide-PBI 8 compositions of
a DMSO-water solvent system were chosen. Figure 4.2 shows spectra of peptide-
PBI 8 in solvent mixtures varying from neat DMSO to neat water. Upon addition
of small percentages of water to the DMSO solution there is a decrease in vibronic
peak intensity and concurrently a broadening of the spectrum at longer wavelengths.
These spectral characteristics indicate the π-π aggregation of peptide-PBI 8 in wa-
ter. Figure 4.3 shows how the vibronic peak ratio varies with solvent composition
illustrating the progression from monomers at high DMSO concentration (≥60%
DMSO), to cofacial H-aggregates with water additions.
At high DMSO concentration the vibronic peak ratio of 0.6 reﬂects that of a PBI
core that is not coupled to other chromophores (determined from dilute solution of
alkyl-PBI 11). Small to moderate additions of water (<40% v/v) appear to have no
signiﬁcant eﬀect on the aggregation state of peptide-PBI 8, indicating the resistance
to moderate changes in solvent composition. Assembly of monomers is induced when
the percentage of water is increased to approximately 50%. At this composition the
PBI core is unable to be eﬃciently solvated due to its large hydrophobicity and
the molecules assemble in order to reduce interactions between water and the PBI
core. Cofacial aggregate formation allows the hydrophobic PBI core to be embedded
in an aggregate, whilst the hydrophilic peptide is solvated. This driving force for
cofacial aggregate formation grows as the water content increases further until the
spectroscopic signatures begin to appear very similar to those of peptide-PBI 8 in
neat water. This means that peptide-PBI 8 has a high propensity to self-assemble
into H-aggregates in solvent compositions with a large percentage of water.
These results illustrate the control over aggregation of peptide-PBI 8 by varying
solvent compositions from neat DMSO to neat water. It is demonstrated that al-
though monomers appear to be resistant to small additions of a bad solvent, once
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Figure 4.2 UV-Vis absorption spectra of peptide-PBI 8 (3.0×10−6 m) in various
percentage compositions of DMSO and H2O (v/v).
Figure 4.3 Vibronic peak ratios extracted from the spectral series in Figure 4.2
as a function of solvent composition. Also depicted is a schematic illustrating the
nature of PBI molecules in solution.
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a particular threshold is reached the hydrophobicity of the molecules overwhelms
the solvation ability and aggregation occurs. Recently, a study reported the solvent
induced aggregation of a chiral lactose-PBI derivative using the same binary solvent
of DMSO and water.117 The results of this study agree with the observations made
with peptide-PBI 8, i.e., increasing the concentration of water in DMSO leads to
the appearance of aggregates in solution with the likely driving force being the hy-
drophobicity of PBI cores. The authors of that study also reported the appearance
of circular dichorism spectroscopy (CD) bisignate signals as a function of increasing
water percentage. These signals are a result of the chiral design of their lactose-PBI
derivative and support the conclusions of solvent induced aggregation. Unfortu-
nately CD spectra for peptide-PBI 8 for diﬀerent solvent compositions were unable
to be obtained due to time constraints. However, based on results reported in the
literature and the spectral broadening seen with peptide-PBI 8, it is almost certain
that a CD signal would be observed at water percentages greater than 50%, ap-
proximately the point at which the population of aggregates reaches a considerable
level.
4.3 Reorganisation of peptide-PBI aggregates
A corollary of varying solvent composition to tune aggregation can be applied with
two solvents that are not entirely good or bad but induce diﬀerent types of aggre-
gates. Recall that in acetonitrile (MeCN) there are strong π-π interactions between
neighbouring PBIs for peptide-PBI 8. In order to investigate the sensitivity of these
strongly coupled aggregates to solvent compositions, a solvent system of varying
percentages of MeCN and water was prepared. This binary solvent system is inter-
esting because peptide-precursor 3 (NH2-Gly-Ala-Ala-Ala-Glu-Glu-Glu) formed an
organogel when dissolved in MeCN (see Chapter 3); indicating it is a poor solvent
for the peptide segment of peptide-PBI 8. However, MeCN is a good solvent for
perylene and thus it should be able to solvate the π-face of peptide-PBI 8.
Figure 4.4 shows UV-Vis spectra of peptide-PBI 8 in solvent mixtures varying from
neat MeCN to neat water. Upon addition of a small percentage of water to the
MeCN solution, vibronic peaks begin to emerge. These peaks continually emerge
with each increase in water addition, with A0−0 being the most intense in the pro-
gression. The emergence of vibronic peaks implies water weakens the π-π coupling
between neighbouring peptide-PBI 8. At high water concentrations there is a redis-
tribution of vibronic peak intensities and A0−1 increases, indicating a reorganisation
of aggregates caused by water addition.
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Figure 4.4 UV-Vis absorption spectra of peptide-PBI 8 (3.0×10−6 m) in various
percentage compositions of MeCN and H2O (v/v).
In order to gain further insight into this reorganisation process a more detailed
analysis was conducted. Particularly useful information can be gained from changes
in vibronic peak ratios and the fraction of vibronically structured components. In
order to obtain this information some basic signal processing was performed on
the MeCN/water spectral series, in particular the subtraction of the MeCN-like
character from the other signals. This spectral processing was performed on the basis
that oscillator strength is quantitatively redistributed from the broad signature (in
MeCN) to a more structured vibronic progression,19 allowing for the each spectrum
to be well ﬁt to a linear combination of the MeCN and the structured vibronic
spectrum.
Linear combinations were calculated by scaling the broad spectrum (MeCN) to the
spectrum of interest (e.g. solution with some percentage of water) at 575 nm. This
is approximately the centre of the shoulder at longer wavelengths observed in the
MeCN spectrum. The scaled broad aggregate spectrum is then subtracted from the
spectrum of interest and the vibronically structured component is elucidated. The
vibronic ratio was calculated from this vibronic component (i.e., after subtraction).
The vibronic fraction was determined based on the vibronic component area and
the initial spectrum area, as given on equation 4.1.
Vibronic Fraction =
AreaVibronic Component
AreaTotal
(4.1)
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Figure 4.5 illustrates how the fraction of the vibronically structured component
varies with solvent composition. This analysis reveals three distinct regions: 1)
A strongly coupled aggregate with a broad absorption at <5% water, 2) A rapidly
increasing fraction of chromophores whose spectra resemble monomers with water
addition, and 3) Formation of a diﬀerent type of aggregate with vibronic structure
at high (>80%) water content. Figure 4.5 also shows that the ﬂuorescence inten-
sity and vibronic peak ratios follow the population of monomers (i.e., the vibronic
fraction as a function of solvent composition).
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Figure 4.5 Fraction of peptide-PBI 8 chromophores with resolved vibronic peaks
extracted from the spectral series in Figure 4.4, revealing three distinct regions.
Also shown are the vibronic peak ratios (after the broad component is subtracted)
and the ﬂuorescence intensity, excitation wavelength for all spectra was at the 0-0
vibronic peak.
The emission spectra provide supporting evidence for these three distinct regions. In
region 1 the system is weakly ﬂuorescent, matching the excimer emission obtained
for peptide-PBI 8 in MeCN (see chapter 3). This excimer emission is red-shifted to
approximately 655 nm whereas the strong emission throughout region 2 is centred at
approximately 544 nm. This strong emission matches that expected from isolated
PBI chromophores, for example dilute alkyl-PBI 11 in chloroform. Observations
that region 2 contains a signiﬁcant fraction of monomers is supported by the vibronic
peak ratio. Up to 80% water sees the constant ratio of approximately 0.6, this reﬂects
a PBI core that is not coupled to other chromophores (comparable to that of alkyl-
PBI 11). However at high water percentages there is a redistribution of vibronic
peak intensitites in favour of A0−1 over A0−0 and they become almost equal, even
after subtraction of the underlying broad component. This change in vibronic peak
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ratio is a characteristic signature of H-aggregate formation (as discussed in chapter
3). The aggregate present at high water percentage is signiﬁcantly diﬀerent from the
origin (i.e.,MeCN) and depicts the reorganisation ability in MeCN-water percentage
compositions.
The next stage of the investigation of solvent composition dependent aggregation
was to elucidate the driving force of the reorganisation of aggregates in MeCN and
water compositions. Recall that pH dependent spectra (Chapter 3) indicated that
electrostatic repulsion provided the impetus for twisted H-aggregate formation in
neutral water. The signiﬁcantly higher pKa of carboxylic acids in MeCN (pKa
acetic acid in MeCN is approximately 24) ensures that the glutamic acid residues
remain protonated initially.118 This suggests that the reorganisation from a tightly
coupled aggregate into monomers could be driven by electrostatic repulsion between
ionised glutamic acid residues (i.e., going from region 1 to region 2, based on the
introduction of water causing dissociation of carboxylic acid protons).
To conﬁrm this, the solvent composition dependence of peptide-PBI 8 was repeated
in the presence of an electrolyte to screen electrostatic repulsions. The salt additive
used as an electrolyte was sodium perchlorate and was chosen on the basis that
it is soluble in both water and MeCN. At the same time, the solvent composition
dependence of peptide-PBI 9 was carried out. This peptide-PBI conjugate contains
two less ionisable glutamic acid residues than that of peptide-PBI 8 and can therefore
be used to elucidate the role of electrostatic repulsions through direct comparison.
Figure 4.6 shows the resulting vibronic fraction extracted from the spectral series
of both peptide-PBI 8 and 9 with and without salt additions, the region indicators
are the same as described in Figure 4.5. These quantities were obtained in the same
manner as previously described, using the corresponding broad MeCN signature for
each experiment. The change in vibronic fraction with and without salt indicates
that the transition from region 1 to region 2 is suppressed in the presence of an elec-
trolyte. Additionally the solvent composition dependence of peptide-PBI 9 shows
that more water is needed in order to initiate the reorganisation of aggregates. This
implies that the transition from strongly coupled aggregates to monomers is pro-
moted by accommodating the charge formation on the peptide sequence when small
percentages of water are added.
Electrostatic repulsion inducing the reorganisation is clearly observed in the com-
parison of the solvent composition dependence of peptide-PBI 8 with and with-
out electrolyte additions. When electrolytes are present the transition from region
1 to region 2 occurs at approximately 20% water content instead of <5%. This
58
0 20 40 60 80 100
0.0
0.2
0.4
0.6
0.8
1.0
 
 Peptide-PBI 8 no electrolyte
 Peptide-PBI 8 with 10-3 M NaClO
4
 Peptide-PBI 9 no electrolyte
 Peptide-PBI 9 with 10-3 M NaClO
4
% H2O in MeCN
V
ib
ro
ni
c 
fra
ct
io
n
1 2 3
Figure 4.6 Fraction of peptide-PBI 8 and 9 chromophores with resolved vibronic
peaks extracted from the corresponding spectral series in of Figure 4.4 with and
without sodium perchlorate. The spectral series for peptide-PBI 9 is not shown but
closely resembles that of peptide-PBI 8 in spectroscopic features.
means that more water is needed to impart enough ionised carboxylic acid groups
to induce reorganisation and overcome the forces inducing aggregation in MeCN.
A similar comparison can be made between the solvent composition experiments
of peptide-PBIs 8 and 9. The reorganisation of peptide-PBI 9 without electrolyte
closely resembles that of peptide-PBI 8 with electrolyte additions conﬁrming that
electrostatic repulsion is the drive for aggregate reorganisation. Peptide-PBI 9 con-
tains two fewer glutamic acid residues, thus reducing the number of ionisable groups
on the molcule which has the same eﬀect as screening the charge using electrolytes.
This is supported by the results of an experiment involving the addition of elec-
trolyte to solvent compositions of peptide-PBI 9. The charge screening eﬀect of the
electrolyte ions in solution has little eﬀect on the amount of water required to induce
reorganisation, as evidenced by the vibronic fractions being near identical with and
without salt additions. Notably, the absolute value of the vibronic fractions between
the two peptide-PBI conjugate experiments are signiﬁcantly diﬀerent. The order of
two diﬀerence between the the two peptide-PBI conjugates implies that peptide-
PBI 9 generates twice the population of vibronically structured chromophores than
peptide-PBI 8 at 1:1 MeCN:H2O composition. The reason this is considered to be
an erroneous comparison is that 9 has less ionisable groups and therefore the re-
pulsive forces are diminished compared to 8. This leads to the conclusion that this
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diﬀerence in absolute value is possibly an artefact from the method of derivation of
the vibronic fraction, possibly caused from the H-aggregate signature of peptide-PBI
6 overlapping more with the ‘MeCN tail’ at longer wavelengths.
Recall that the vibronic fraction is derived based on a linear progression of a broad
aggregate spectrum and a vibronically structured spectrum at one wavelength (575
nm). This is a simpliﬁcation of the linear progression as it is expected there
will be more than two components comprising the spectrum in water, for example
monomers, H-aggregates and broad aggregate signals. Also the linear progression
analysis conducted here was only performed at one wavelength, whereas the spectral
features being considered span a considerable portion of the visible spectrum. In
order to derive more accurate absolute values of the vibronic fraction more sophis-
ticated analysis techniques could be utilised.
One approach could be using singular value decomposition (SVD) which has been
applied to relatively complicated linear combinations in various spectroscopic ex-
periment set-ups in the literature.119,120 Methods such as SVD are able to consider
several components of a linear progressions over a range of wavelengths and therefore
the simpliﬁcation utilised in this work is not required. It is worthy to note however
that the diﬀerence between values (i.e., those calculated in this work and those by
SVD) are predicted to only diﬀer in the absolute value, meaning that the overall
trend (and relative relationship between experiments) should remain the same.
4.4 Summary
In summary, this chapter demonstrates the ability to tune the nature of peptide-
PBI conjugates in solution by taking advantage of the amphiphilic nature of the
molecules. The diverse solvation demands incorporated in the design of peptide-PBI
conjugates allow the solvent compositions percentages of a good solvent (DMSO)
and a relatively bad solvent (water) to be varied in order to control aggregation.
This type of experiment is able to induce aggregation of well solvated monomers into
cofacial H-aggregates, as determined by monitoring the vibronic peak ratio as a func-
tion of solvent composition. Results from this experiment illustrate that although
monomers are resistant to moderate additions of poor solvent (i.e., monomers re-
main at < 40% water composition) it is the unfavourable interactions between the
water and hydrophobic PBI core that provide the impetus for assembly.
Additionally this chapter demonstrates controlled reorganisation of peptide-PBI ag-
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Scheme 4.1 Mechanism of the reorganisation of 8 upon; a) moving from neat
MeCN to a MeCN/H2O mixture, b) going to a high percentage composition of H2O.
The regions labelled 1, 2 and 3 correspond to those in Figure 4.5, and detailed in
the text.
gregates by varying the solvent composition of two solvents that induce diﬀerent
aggregation types, namely MeCN and water. This binary solvent system induces
a change from a strongly coupled aggregate (in MeCN) to a weakly coupled H-
aggregate driven by electrostatic repulsion between ionisable groups on the pep-
tide. A possible mechanism for this reorganisation was deduced by comparing the
spectral analysis data for two peptide-PBI conjugate and by using electrolytes, a
schematic of this is depicted in Scheme 4.1. This work demonstrates the ability of
peptides to impart diverse solvation characteristics to PBI derivatives and provide a
‘control-handle’ for controlling the nature PBI aggregation in solution. The concept
presented may ﬁnd application in organic devices such as biosensors by monitoring
the increased photoluminescence that occurs upon reorganisation.
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Chapter 5
Counterion effects on peptide-PBI
aggregation
5.1 Introduction
In nature, there are numerous complex functional systems which are composed of
units organised hierarchically through multiple noncovalent interactions, typically
over several length scales.121,122 One approach that is commonly employed to ob-
tain supramolecular structures is through mixing diﬀerent building blocks that are
able to interact.123 A classic example of this is the incorporation of cyanuric acid
moieties into functional building blocks so that upon addition of melamine, com-
plexation occurs between the molecules which aids in directing supramolecular as-
sembly.124 There are numerous examples reported in the literature demonstrating
the ability of additives to direct (or change) the self-assembly of PBI derivatives in
solution.31,34,35,125–127
A corollary of varying additives to control the supramolecular structure involves
the coupling of diﬀerent molecular units by exploiting electrostatic interactions,
commonly referred to as ionic self-assembly.128 This technique provides a ﬂexible
method for the controlled assembly of molecular units, and has been utilised in the
formation of various dye-surfactant supramolecular structures,129,130 including PBI
derivatives.131,132 One particular adaptation of this approach is to use metal ions to
induce assembly instead of surfactants. The desire to obtain functional materials
sensitive to the presence of ions has received considerable attention, largely driven by
the promise these materials have in recognition and sensor applications.133–135 The
principle of organic semiconductor based sensor devices typically relies on monitoring
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spectroscopic changes, either absorption or photoluminescence, in the presence (or
absence) of target ions.136 It is noteworthy that there are only a few reports of PBI
derivatives being employed in ﬂuorometric and colorimetric sensor devices for the
detection of ions in the literature.137,138
This chapter investigates the sensitivity of peptide-PBI aggregates (in particular
peptide-PBI 8 and 9, see Figure 5.1) to the presence of metal cations in aqueous so-
lutions. By monitoring the spectroscopic signature of a weakly coupled H-aggregate
as a function of ionic strength, we demonstrate the ability to reduce the twisting
between PBI cores through non-speciﬁc ion interactions. Additionally it is demon-
strated that metal cations with a propensity to form metal-carboxylate complexes
can induce cross-linking of peptide-PBI conjugate molecules. These types of inter-
actions were elucidated by varying the type of salt used and take advantage of the
ionisable glutamic acid side chains being deprotonated at neutral pH.
NN
O
O
O
O
RR
Gly (Ala)3 (Glu)3   : R= OH
Gly (Ala)3 (Glu) : R= OH
8
9
Figure 5.1 Key compounds utilised to investigate the types of interactions that
can occur with diﬀerent metal cations in solution.
5.2 Sensitivity of PBI aggregates to ionic strength
The design features incorporated into the peptide-PBI conjugates was based on
commonly employed peptide amphiphile structures (see Chapter 3). Of particular
interest in this section is that of the glutamic acid residues, which bear an ionisable
carboxylic acid side chain. In distilled water, this ionisable side chain is present in the
ionised state, (i.e., negatively charged deprotonated carboxylate group). Illustrated
previously in this work (Chapter 3) these ionisable glutamic acid residues impart
pH sensitivity to peptide-PBI conjugates. A further implication of this is that the
aggregates are also sensitive to ionic strength alterations in aqueous solutions (i.e.,
the presence of ions in solution). This section is concerned with the ionic strength
sensitivity of peptide-PBI 8 aggregates, and illustrates the ability to induce stronger
PBI core overlap via addition of positively charged ions which screen the negative
charges present on peptide segments, thus reducing electrostatic repulsion between
peptide-PBI 8 molecules.
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In order to investigate the sensitivity of peptide-PBI 8 aggregates to ionic strength,
aqueous solutions of sodium perchlorate (NaClO4) of various concentrations were
prepared. Figure 5.2 shows spectra of peptide-PBI 8 in the presence of varying
concentrations of NaClO4 in water, normalised at the [0-1] peak. Upon the addition
of ions to the solution there is a decrease in the intensity of the [0-0] vibronic
peak, indicative of increasing H-aggregate character (i.e., more eﬀective cofacial π-
π interactions of peptide-PBI 8 in solution). Figure 5.3 shows how the vibronic peak
ratio, and emission intensity varies with the concentration of NaClO4 and illustrates
the progression of an H-aggregate with a large twist between units (from electrostatic
repulsion), to an H-aggregate with less twisting, due to Na+ ions screening the charge
on glutamic acid residues.
These results show the sensitivity of peptide-PBI 8 to the presence of Na+ ions in
solution. The positively charged ions in solution enables charge screening of the
glutamic acid residues, which causes an increase in π-orbital overlap, supported by
the emission intensity which decreases as the concentration of Na+ ions increases.
This alteration in H-aggregate character is a subtle eﬀect as the change in vibronic
peak ratio occurs very gradually over a relatively large concentration range of Na+.
Such a small change in aggregate signature is consistent with a non-speciﬁc ion
screening eﬀect as opposed to a direct ion interaction.
In comparison, a recent study reported the sensitivity of a PBI derivative (which fea-
tured two ﬁrst generation Newkome type dendrimers) to Na+ ion concentration.139
The results of this study concur with the observations made with peptide-PBI 8.
That is, in the presence of Na+ ions the aggregation (and subsequent π-π interac-
tions) are enhanced, as evidenced by emission intensities and vibronic peak ratio
changes. The authors of that study also investigate the eﬀects of Li+ and K+ on
the aggregation and ﬁnd that the PBI aggregation is enhanced in the presence of all
these ions.
Interestingly, the authors observe that these three alkali metal ions are able to
enhance slightly diﬀerent amounts of aggregation of the Newkome-PBI derivative.
This was determined by treating the PBI-derivative as a surfactant molecule and
the critical micelle concentration (cmc) was calculated. From these calculations it
was reported that there was a slight diﬀerence of enhanced aggregation between Na+
and K+ ions (i.e., cmc for Na+ 0.94 × 10−5 m, and 1.18 × 10−5 m for K+). From
this result the authors conclude that Na+ ions have a slightly higher aﬃnity towards
carboxylate groups. Regarding the investigations of the sensitivity of peptide-PBI
8 to ionic strength presented in this section, only Na+ ions were utilised. However,
based on the results reported in the literature it is expected that the other alkali
64
400 500 600 700
 
 
N
or
m
al
is
ed
 A
bs
or
ba
nc
e 
(A
U
)
Wavelength (nm)
 0 M
 8.5E-5 M
 1.7E-4 M
 3.4E-4 M
 6.8E-4 M
 1.4E-3 M
Conc. of NaClO4
Figure 5.2 UV-Vis absorption spectra of peptide-PBI 8 (3.0 × 10−6 m) in the
presence of various concentrations of NaClO4 in water. The arrow indicates changes
in A0−0 upon increasing the concentration of Na
+ ions in solution.
Figure 5.3 Vibronic peak ratios extracted from the spectral series shown in
Figure 5.2, and emission intensity of peptide-PBI 8 as a function of NaClO4 concen-
tration. Also depicted is a schematic illustrating the nature of PBI aggregates upon
increasing the concentration of NaClO4. The excitation wavelength for all emission
spectra was at the [0-0] vibronic peak.
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metal ions would enhance the H-aggregate of peptide-PBI 8 to a very similar extent
to that of Na+ ions.
5.3 Cross-linking of PBI aggregates via specific
ion binding
The sensitivity of a Newkome-PBI derivative reported in the literature indicates
that enhancing the aggregation of PBI molecules via the addition of ions to solution
is likely not solely due to ionic strength variations (discussed in detail above).139
This study reported the enhancement of PBI aggregates via the addition of mono-
valent counterions, and illustrated that Na+ ions were able enhance aggregation to a
greater extent than K+ ions. This section focusses on the investigation as to the inﬂu-
ence various ions have on peptide-PBI aggregates, namely the diﬀerences observed
between monovalent cations, coordinating divalent cations, and non-coordinating
divalent cations. The results show that with ions with a high propensity to form
metal-carboxylate complexes, speciﬁc ion binding can occur which is able to cross-
link peptide-PBI aggregates.
Figure 5.4 shows the UV-Vis spectra of peptide-PBI 8 with various types of salts
at a constant ionic strength of 6.8 × 10−4 m. These data clearly shows that the
enhancement of peptide-PBI 8 aggregation is dependent on the type of cation em-
ployed. All Na+ containing salts show similar changes in the relative intensity of the
[0-0] vibronic peak intensity compared to the [0-1] peak intensity. In contrast, the
use of divalent cations (like Zn2+) show a greater reduction in the [0-0] vibronic peak
intensity than that observed for monovalent Na+ ions. Interestingly, the divalent
cation that is already ligated ([Cu(ethylenediamine)2]
2+) imparts changes that are
similar to monovalent cation additions. The observations of enhanced H-aggregate
formation of peptide-PBI 8 from the relative vibronic peak intensities is valid be-
cause all salt solutions were of the same ionic strength. This means that the eﬀects
observed are directly related to the type of cation used, not due to alterations in ion
concentration.
In order to gain insight into the cause of diﬀerent ion eﬀects on peptide-PBI 8
aggregates a more detailed analysis was conducted. Useful information is gained
from observing changes in vibronic peak ratios in relation to the various ions used.
Figure 5.5 illustrates how the vibronic peak ratios changes upon varying the ionic
strength of the same salts shown in the spectral series in Figure 5.4. This analysis
reveals two distinct types of ion interactions, 1) A large change in the vibronic
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Figure 5.4 UV-Vis absorption spectra of peptide-PBI 8 (3.0 × 10−6 m) in the
presence of various salts. All salt solutions have the ionic strength of 6.8× 10−4 m.
Also included is the spectra of peptide-PBI 8 (3.0 × 10−6 m) in distilled H2O and
DMSO for comparison.
peak ratio with divalent cations which are able to coordinate carboxylate groups
(e.g. Zn2+ or Mg2+), and 2) A small change in the vibronic peak ratio with non-
coordinating cations (e.g. Na+ or [Cu(en)2]
2+, where ‘en’ is ethylenediamine) in
which modiﬁcations to aggregate nature is caused by variations in charge screening
(i.e., ionic strength).
To investigate the change imparted by each diﬀerent ion, it was ﬁrst important
to determine if the anion has an eﬀect on modifying the nature of peptide-PBI
8 H-aggregates. This was achieved by selecting salts with the same cation (e.g.
Na+) and vary the type of anion of salts used. Comparing NaClO4 with NaCl
shows overlapping vibronic peak ratio changes, illustrating similar enhancement of
peptide-PBI 8 aggregation. The only diﬀerence between the two salts is the type of
anion, therefore this result indicates that monovalent anions have no inﬂuence on H-
aggregate twist reductions. To interrogate this further, sodium sulfate (Na2SO4) was
used and was shown to have the same vibronic peak ratio changes as the both NaCl
and NaClO4 as a function of ionic strength. Overlapping changes in the vibronic
peak ratio for all Na+ salts indicate that divalent anions also have no eﬀect. This lack
of anion involvement in changing the nature of peptide-PBI 8 aggregates is further
supported with ZnSO4 and Zn(OAc)2 comparisons, which show these two salts have
overlapping vibronic peak ratio changes. These results combine to conclusively show
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Figure 5.5 Changes in vibronic peak ratio of peptide-PBI 8 (3.0× 10−6 m) as a
function of ionic strength of various salts. Ratios were extracted from the spectral
series presented in Figure 5.4, and depict two distinct ion eﬀects. Region 1 involves
speciﬁc ion binding, whilst Region 2 involves non-speciﬁc ion screening. Note ‘en’
in Cu(en)2SO4 represents the bidentate ligand ethylenediamine.
that the anion has no inﬂuence in increasing the degree of π-π interactions within
H-aggregates of peptide-PBI 8.
The next stage of analysis focussed on determining the cause of the large vibronic
peak ratio changes for the divalent cations Zn2+ and Mg2+. One signiﬁcant diﬀerence
between these divalent cations and Na+ ions (apart from the increased charge) is
that Zn2+ and Mg2+ are able to coordinate to oxygen atoms to form bidentate metal-
carboxylate complexes.140–142 This implies that the large increase in vibronic peak
ratio observed for the zinc and magnesium salts is caused by direct ion binding of
carboxylate groups of the glutamic acid residues in peptide-PBI 8 (i.e., chelation of
two carboxylate groups to the divalent metal ion). This implies that there is a direct
ion interaction with peptide-PBI 8 molecules, and not simply charge screening for
these types of ions. Interestingly, the data presented in Figure 5.5 shows that this
ion interaction also depends on the type of coordinating ion used, which implies
that this divalent interaction is ion-speciﬁc. This is indicated by diﬀerence in total
vibronic peak ratio changes for Zn2+ and Mg2+ ions.
This diﬀerence can be explained upon consideration of a study reported in 1970 by
Bunting et al. which investigated the stability constants of various metal carboxy-
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late complexes.143 The authors report that there is a higher stability constant for
metal-carboxylate complexes involving Zn2+ compared to Mg2+ for all carboxylate
anions that were investigated. This greater stability constant for Zn2+ containing
complexes implies that the propensity for complexation is greater for Zn2+ ions than
for Mg2+ ions. Applying the ﬁndings from the literature to peptide-PBI 8 interac-
tions with these two metal ions shows that the diﬀerence in reducing the twisting in
H-aggregates, between the coordinating metal ions, is explained based on the rela-
tive propensity of the metal cation to form a carboxylate complex. Therefore this
explains why a greater enhancement of H-aggregate spectroscopic signals is observed
for Zn2+ ions than Mg2+ when at the same ionic strength.
To probe the hypothesis that metal-carboxylate complex formation is the mech-
anism involved in the enhancement of H-aggregate character (as opposed to only
ionic strength), the comparisons to the non-coordinating copper salt (Cu(en)2SO4)
becomes very signiﬁcant. The cation in this metal salt involves a copper(II) centre
with two ethylenediamine groups chelated. The cation, in this copper complex, is
divalent but the copper lacks the ability to form a carboxylate complex with glu-
tamic acid residues, therefore removing the ability for a direct ion interaction. The
change in the vibronic peak ratio for this copper salt overlaps with the sodium salt
ratios (see Figure 5.5). This provides conclusive evidence that ions unable to coor-
dinate carboxylate groups cause a reduced twisting within peptide-PBI conjugate
H-aggregates through non-speciﬁc charge screening. Whereas, ions with the abil-
ity to coordinate carboxylate groups have a greater eﬀect on reducing the twisting
between molecules within the H-aggregate.
With results showing that peptide-PBI 8 aggregate sensitivity to ions is ion spe-
ciﬁc and can be caused by direct ion interactions, investigations were conducted to
determine how the formation of metal-carboxylate complexes causes such a large
change in the vibronic peak ratio. In order to determine if the binding of glutamic
acid groups involves an inter- or intra-molecular complexation to a metal ion, the
ion-sensitivity of peptide-PBI 8 was compared to aggregates of peptide-PBI 9. The
comparison of spectroscopic changes for these two peptide-PBI conjugates aid in
elucidating the mechanism because peptide-PBI 9 contains only one glutamic acid
residue on each peptide segment, as opposed to the three contained in peptide-PBI
8. Figure 5.6 illustrates the changes in vibronic peak ratios as a function of ionic
strength for NaCl and Zn(OAc)2 for those two peptide-PBI conjugates. The data
indicates that the addition of Zn2+ ions has the same eﬀect on both peptide-PBI con-
jugates. This provides evidence that the metal carboxylate complex that is formed is
able to form even with the reduced number of glutamic acid residues of peptide-PBI
9 (compared to peptide-PBI 8).
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Figure 5.6 Changes in vibronic peak ratio of peptide-PBI 8 (3.0× 10−6 m) and
peptide-PBI 9 (3.0 × 10−6 m) with Zn(OAc)2 and NaCl as a function of ionic
strength. Ratios were extracted from the corresponding spectral series to that de-
picted in Figure 5.2.
The absolute value of the vibronic peak ratios for both peptide-PBI conjugates is re-
lated back to the molecular structure of the compounds and the behaviour in water
(see Chapter 3), and imparts no diﬀerence in data analysis. However, an important
observation is that the vibronic ratio as a function of ionic strength increases in the
same manner for the two peptide-PBI conjugates. Due to peptide-PBI 9 having only
one glutamic acid residue on each peptide segment on, the chelation of two carboxy-
late groups is therefore extremely likely to be occurring with carboxylate groups on
diﬀerent molecular building blocks. Although this is not conﬁrmed for certain, the
conclusion is reached based on improbability that the distance between the terminal
carboxylic acid and the glutamic acid side chain is small enough such that a divalent
metal ion (e.g. Zn2+) is able to coordinate to both carboxylic acid hydroxyl-groups.
However, if the metal ion is coordinated to one glutamic acid carboxylic acid group,
it is likely that the neighbouring peptide-PBI conjugate glutamic acid residue will
be in relative close proximity to the metal ion, thus allowing the coordination of two
glutamic acid residues on diﬀerent H-aggregate units.
From these comparisons a possible mechanism for the enhanced H-aggregate sig-
natures by the addition of ions can be elucidated. Due to the negatively charged
glutamic acid residues in water, cations in solution will be attracted to the peptide-
PBI aggregates. When these cations have no direct interaction with the negative
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charge the reduced twist is caused by charge screening, and is a non-speciﬁc ion inter-
action. However, if the ion is able to coordinate to the carboxylate groups (and form
a metal-carboxylate complex) then neighbouring peptide-PBI molecules are cross-
linked due to metal complex formation, which imparts intermolecular non-covalent
interactions. This interaction is shown to be ion speciﬁc due to the interaction being
strongly dependent on the metal ions propensity to form metal-carboxylate com-
plexes. Nevertheless, the cross-linking interaction signiﬁcantly reduces the twisting
within an aggregate, yielding more eﬀective π-orbital overlap of PBI cores, thus a
large increase in H-aggregate signature is observed. These two types of interactions
are depicted in Scheme 5.1.
Scheme 5.1 Summary of the two types of interactions that can occur with peptide-
PBI conjugates and diﬀerent metal cations. a) Non-coordinating metal cations ex-
hibit a non-speciﬁc ion interaction in which no direct interaction occurs but assembly
is changed due to charge screening, and b) Metal cations with the ability to form
metal-carboxylate complexes cross-link peptide-PBI conjugates through intermolec-
ular non-covalent interactions. Cross-linking involves a direct interaction and is
shown to be ion speciﬁc enhancing H-aggregate signatures to a greater extent than
ion screening.
These results indicate the potential for peptide-PBI conjugates to be used as cation
sensors, however further investigations need to be carried out to determine the in-
teractions with various other metal ions (e.g. other transition metal ions). Such ex-
periments could determine the stability constants of peptide-PBI metal-carboxylate
complexes to examine if there is a high degree of coordination of a particular metal
ion. Also, variations in the type of amino acid employed would be interesting to
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investigate. For example, there are results in peptide amphiphile literature which
show the ability to seed nanoparticles on aggregate via the chelation of Fe2+ to the
amino acid histidine.144
5.4 Summary
In summary, this chapter illustrates that peptide-PBI aggregates are sensitive to
the presence of ions in solution, due to the ionised glutamic acid residues present in
the peptide sequence. The twist between molecules in the peptide-PBI H-aggregate
is a result of electrostatic repulsion between neighbouring molecules. Investigations
into the sensitivity of these aggregates to the addition of Na+ involved monitoring
the spectroscopic changes that occur as a function of ionic strength. These results
showed that weakly coupled H-aggregate signatures were enhanced upon the addi-
tion of Na+ ions. The same spectroscopic changes were also observed for the divalent
non-coordinating cation [Cu(en)2]
2+, indicating that this is a non-speciﬁc ion inter-
action and the reduction in twisting is caused by cations screening the negative
charges on glutamic acid residues.
Additionally, this chapter demonstrated that although non-coordinating cations
have no direct interaction, divalent metal cations with a propensity to form metal-
carboxylate complexes can impart a large reduction in H-aggregate twisting. This
was achieved by monitoring spectroscopic changes as a function of ionic strength us-
ing Zn2+ and Mg2+ salts, and comparing the relative change to the non-coordinating
metal ions. The analysis illustrated that Zn2+ and Mg2+ ions are able to form
peptide-PBI intermolecular metal-carboxylate complexes which cross-link neigh-
bouring molecules in solution. Further to this being a direct interaction, it is also
illustrated to be ion selective due to diﬀerent amounts of twist reduction between
metal ion complexation. A schematic of the two types of metal ion interactions that
are demonstrated in this chapter is presented in Scheme 5.1. The concept presented
may ﬁnd application in cation sensor and recognition devices by monitoring the
spectroscopic changes that occur in the presence of cations in solution.
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Chapter 6
Conclusions
In conclusion, through the combination of two well established synthetic protocols,
a series of peptides were symmetrically tethered to a PBI core. The presence, and
type, of aggregates in solution was elucidated through interpreting the perturba-
tions of monomer optical spectroscopic signatures. By applying the exciton model
it was determined that weakly coupled H-aggregates were formed by the peptide-
PBI conjugates in water. Employing various peptide designs allowed the inﬂuence of
the peptide on assembly to be deduced, and no evidence of H-bonding knitting to-
gether PBI chromophores was observed. However, reducing the number of ionisable
groups, or increasing steric bulk signiﬁcantly alters the electronic coupling between
chromophores.
The tuneability of PBI aggregates was demonstrated through the use of solvent
compositions, which allowed semicrystalline PBI aggregates to undergo controlled
reorganisation into weakly coupled H-aggregates, with the introduction of electro-
static repulsions between peptide segments the driving force. The PBI aggregates in
water were also shown to be sensitive to metal cation additions in solution, through
interactions with the glutamic acid residues. A key result is that cations are ca-
pable of forming metal-carboxylate complexes which are able to cross-link adjacent
chromophores, thereby reducing twisting within the H-aggregate.
While there are a few recent reports of peptide-conjugated organic dyes, studies
have been limited to the observation of aggregation (i.e., converting between an
aggregated and non-aggregated state). This work successfully demonstrates the
ability of peptide segments to drive the assembly of PBI chromophores; moreover,
the peptide design imparts the ability to switch between diﬀerent types of aggregate
states and to ﬁnely tune the conﬁguration within a given state.
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Chapter 7
Future Work
The controlled assembly of PBI chromophores is a signiﬁcant step toward device
application, although future work directed towards transferring the aggregates into
thin ﬁlms is certainly necessary. Solid state devices are the most common in the ﬁeld
of organic electronics, therefore transferring the knowledge of controlled aggregation
in solution into thin ﬁlms is far more applicable to device fabrication.
An interesting path for future work would be a detailed investigation of ﬁbre forma-
tion in solution, particularly through the use of cryo-TEM, which was not available
at this institution at the time of this work. However, international collaborators
have emerged that have now made this a possibility. Such investigations would en-
able insight into the geometry of PBI chromophores in the ﬁbre, potentially allowing
a mechanism of ﬁbre formation to be elucidated. Information of this nature could
allow various design aspects to be incorporated to obtain diﬀerent supramolecular
architectures.
Another avenue of future work would be a thorough investigation into the ability
of the peptide sequence to induce the formation of chiral aggregates. The initial
CD results obtained in this work demonstrated the potential that chiral amino acid
residues close to the PBI core are able to cause exciton signatures of helical cofa-
cial PBI aggregates. Future experiments would almost certainly require the use of
comparing the d- and l-amino acids in order to determine that the absolute con-
ﬁguration of the amino acid drive the chiral aggregate formation. These could lead
to chiro-optical sensing devices for the detection of biomolecules which possess an
absolute conﬁguration of interest.
One other interesting future investigation would be to alter the molecular design
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so as to obtain asymmetric peptide-PBI derivatives. In particular, the use of an
alkyl tail at one imide nitrogen and a peptide sequence at the other. This could al-
low diﬀerent supramolecular architectures to be obtained, which could be elucidated
through comparison with the optical spectroscopic signatures presented in this work.
To this end, an additional asymmetric derivative could be to change a peptide se-
quence to an aptamer for the explorations into biosensors to be investigated further.
Upon inclusion of an aptamer with a binding aﬃnity towards a particular target
analyte could allow for colorimetric biosensor devices. The principle of these would
be based on the nature of aggregates would change in the presence of the particular
analyte. Such sensing devices could ﬁnd application in detecting the presence of
harmful biomolecules which could pose environmental or health hazards.
In a similar vain, future investigations could focus on the sensitivity of aggregates
to various metal ions, other than those explored in this work. Through the inclu-
sion of amino acids that have a propensity to form metal complexes (for example,
histidine and Fe2+ ions) could impart signiﬁcant alterations between neighbouring
chromophores. Exploiting such a tuning of electronic coupling in solution could
extend to the formation of colorimetric (and/or ﬂuorometric) metal ion sensors.
Devices of this nature could be useful for the detection of heavy metal ions in wa-
terways, of particular importance would be metal ions that are toxic to ecosystems
(e.g. manganese, mercury, or lead).
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Chapter 8
Experimental
General Methods
All chemicals were purchased from Sigma-Aldrich (St. Louis, MO) and used as
received, unless otherwise stated. Amino acid derivatives were purchased fromMerck
KGaA (Darmstadt, Germany). Derivatised resin was purchased from AAPPTec
(Louisville, KY, USA) and 2-(1H-benzotriazole-1-yl)–1,1,3,3–tetramethylaminium
hexaﬂuorophosphate (HBTU) was purchased from Nova Biochem. Full 1D and
2D NMR data were obtained on a Varian Direct-Drive spectrometer operating at
600 MHz for 1H and equipped with a HCN coldprobe. All NMR spectra were
referenced internally to residual solvent peaks. Fourier-transform infrared (FT-IR)
spectroscopy was performed with a Perkin Elmer Spectrum One spectrometer using
freshly prepared potassium bromide pellets and recorded in the range of 450-4000
cm−1 and averaged over eight scans. Mass spectra were collected on a Waters Q-
TOF Premier Tandem Mass Spectrometer for all peptide precusors (1, 2, 3, 4 and
5, an Agilent 6530 Series Q-TOF mass spectrometer for alkyl-PBI 11, and MALDI-
MS was collected on an AB SCIEX TOF/TOF 5800 for all peptide-PBI conjugates
(6, 7, 8, 9 and 10) using 2,5-dihydroxybenzoic acid (DHB) as matrix.
Optical absorption spectroscopy measurements
Absorption spectroscopy (UV-Vis) was performed with an Agilent 8453 UV-Visible
spectrophotometer over the range 220-1100 nm using a quartz cuvette with 1 cm
path length. All sample solutions analysed had a total volume of 5 mL. Aqueous
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samples of each peptide-PBI conjugate was prepared by having the desired solution
(e.g. altered pH or aqueous salt solution) then 20 µL of a stock solution (1.3 mg/mL
in H2O) of the relevant peptide-PBI conjugate was added. Solvent composition
samples of peptide-PBI conjugates were prepared by mixing water and the organic
solvent to the desired percentage (by volume) and then adding 20 µL of a stock
solution (1.3 mg/mL in H2O) of the relevant peptide-PBI conjugate to give a series
of individual solution from 0-100% solvent percentage. Samples of alkyl-PBI 11
were prepared by adding 100 µL of a stock solution (0.07 mg/mL in CHCl3) into 5
mL of solvent.
Absorption data analysis
All spectra were baseline corrected (Abs700 nm = 0) before subtracting an aggregate
signal that may be convoluting the spectrum. The absorption spectrum in ace-
tonitrile (MeCN) was used as the aggregate reference spectrum in all cases. This
aggregated spectrum was scaled to match the ‘raw’ absorption at 575 nm and sub-
sequently subtracted from the absorption spectrum of interest with the resulting
spectrum being considered the ‘vibronically structured’ component of the absorp-
tion spectrum. From this ‘vibronically structured’ component the vibronic ratio
(A0-1
A0-0
) and the value of the ‘vibronically structured’ fraction was calculated by divid-
ing its integrated area (on an x-axis of energy) by that area of the raw absorption
spectrum.
Fluorescence spectroscopy measurements
Fluorescence spectroscopy was performed with a Shimadzu RF-5301PC spectroﬂuo-
rophotometer using a quartz cuvette with 1 cm path length and four polished sides,
the slit widths on the spectroﬂuorophotometer were set to 1.5 nm resolution (for
both excitation and emission). All excitation wavelengths were at the 0-0 vibronic
peak position, unless otherwise stated. Samples were prepared as described above.
Emission data analysis
All emission spectra were corrected for absorption by dividing by the optical density
at the ﬂuorescence excitation wavelength.
77
Circular dichroism (CD) spectroscopy measurements
CD spectra were recorded on a Chirascan CD Spectrometer. Experiments were
performed in a quartz cell with a 1 cm path length over the range of 205-500 nm at
25C. Samples were prepared as described above.
Preparation of an organogel
The gelation of peptide precursor 3 was prepared by dissolving 3.8 mg of peptide
3 in 1 mL of acetonitrile (MeCN) and sonicating until all the solid was dissolved
(approximately 1.5 hours), the self supporting organogel was formed overnight with
the solution stored at room temperature. The gelation ability was tested through
the ‘inversion of the vial’ test, as shown in Figure 8.1.
Figure 8.1 Inversion of vial showing organogelation of peptide 3 in MeCN.
Cryogenic scanning electron microscopy
Cryogenic scanning electron microscopy studies were conducted using a Jeol JSM-
6500F ﬁtted with a Gatan Alto 2500 cryo attachment, operated at an accelerating
voltage of 4 kV. To achieve quick freezing (under 1 second) samples were dropped
onto a copper rivet and plunged into a ‘slushy’ nitrogen mixture, consisting of a
mixture of solid and liquid nitrogen at a temperature of -210 ◦C. They were then
mounted to a sample holder and transferred under vacuum to a cryo-preparation
chamber operating at a low temperature of -130 ◦C. A fracture to expose the internal
structure of the samples was achieved using a scalpel to break oﬀ the top of the
frozen droplet. Samples were then sublimated at -95 ◦C for 5 minutes, to enhance
the topological contrast and coated with up to three 120 second sputter coatings
of Pt to allow higher imaging in the SEM. Upon cooling to -130 ◦C samples were
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transferred to the microscope chamber via an interlocked airlock and the microscope
temperature was maintained at -130 ◦C.
Preparation of bis(ethylenediamine) copper(II) sulfate
Copper bisethyleneediamine sulfate (Cu(en)2SO4) was prepared through reﬂuxing
copper sulfate (10 mL, 0.5 m) and ethylenediamine (1.34 mL, 0.02 mol) for approx-
imately 90 minutes. The water is then removed via reduced pressure, and 5 mL of
hot water is added to yield a dark purple solution and allowed to cool. The resulting
dark purple crystals were collected via vacuum ﬁltration and washed with ethanol
and petroleum ether, and dried in an oven at 60 ◦C overnight. IR (KBr): νmax 3299,
3217, 31138, 2964, 2923, 2880, 1582, 1451, 1391, 1336, 1277, 1125, 1044, 985, 975,
616 cm−1.
Peptide synthesis procedures
General procedure
The peptide sequences were synthesised via standard Fmoc-based solid phase pep-
tide synthesis (SPPS) protocols.49 Brieﬂy, approximately 0.5 g of Fmoc-Glu(OtBu)
Wang resin (loading of 0.57 mmolg-1) was swelled in dichloromethane (DCM) for
30 minutes and then washed with dimethylformamide (DMF). Fmoc-deprotection
steps were carried out using 30% piperidine (in DMF) with gentle shaking for 30
minutes and then washed ﬁve times with fresh DMF. Each amino acid coupling step
used 4 mole equivalents (to the loading of resin) of the desired amino acid, 3.95
mole equivalents of HBTU, and 6 mole equivalents of DIPEA (Hu¨nigs base) and
shaken for 20 minutes. The Kaiser test was used to conﬁrm the coupling had gone
to completion. Amino acid derivatives used: Fmoc-Glu(OtBU)-OH, Fmoc-Ala-OH,
Fmoc-Leu-OH and Fmoc-Gly-OH.
Cleavage of the complete peptide sequence involved removing the Fmoc protection
on the terminal amino acid residue, rinsing the resin in DMF (5x) and then DCM
(5x) and allowing the resin to dry by passing a stream of nitrogen gas through
the reaction column. The cleavage solution was a freshly prepared cocktail of
CF3COOH/DCM (3:4 v/v). This was shaken with the resin for 3 hours and then
collected. Fresh cleavage solution was passed through the column and the resin was
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rinsed with DCM. The collected solution was reduced in volume by half and then
added dropwise to 20 mL of cold diethyl ether and allowed to crystallise overnight
to aﬀord the fully deprotected peptide sequence which was collected via vacuum
ﬁltration.
Preparation of H2N–Gly–(Glu)3–OH (1)
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Figure 8.2 Chemical structure of peptide 1
Peptide 1 was obtained using the general procedure described above (Yield: 0.11 g,
72%). 1H-NMR: (600 MHz, DMSO−d6) δH 8.55 (d, JHH = 7.8 Hz, Glu #1), 8.24
(m, 2H, N-H Glu #2, #3), 8.00 (m, 2H, NH2 Gly), 4.41 (m, 1H, C-H Glu #1), 4.25
(m, 1H, C-H Glu #2), 4.18 (m, 1H, C-H Glu #3), 3.56 (m, 2H, CH2 Gly), 2.27
(m, 6H, γ-CH2 Glu #1, #2, #3), 1.84 (m, 6H, β-CH2 Glu #1, #2, #3);
13C-NMR:
(150 MHz, DMSO−d6) δC 174.4, 174.3, 174.2, 173.6, 171.5, 171.0, 166.2, 52.2, 52.1,
51.7, 40.6, 30.5, 30.5, 30.4, 28.4, 27.8, 26.6; HR-ESI-MS: m/z C17H27N4O11 [M+H]
+
calcd 463.1676, found 463.1682.
Preparation of H2N–Gly–(Gly)3–(Glu)3–OH (2)
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Figure 8.3 Chemical structure of peptide 2
Peptide 2 was obtained using the general procedure described above (Yield: 0.15 g,
67%). 1H-NMR: (500 MHz, DMSO−d6) δH 8.62 (t, JHH = 7.2 Hz, N-H Gly #2),
8.30 (t, JHH = 6.6 Hz, N-H Gly #3), 8.17 (d, JHH = 9.0 Hz, N-H Glu #3), 8.13
(t, JHH = 6.6 Hz, N-H Gly #4), 8.02 (m, 4H, NH2 Gly #1; N-H Glu #1, #2),
4.26 (m, 2H, C-H Glu#1, #2), 4.17 (m, 1H, C-H Glu #3), 3.85 (d, JHH = 6.6 Hz,
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CH2 Gly #2), 3.75 (m, 4H, CH2 Gly #3, #4), 3.60 (q, JHH = 7.2 Hz, CH2 Gly
#1), 2.26 (m, 6H, γ-CH2 Glu #1, #2, #3), 1.84 (m, 6H, β-CH2 Glu #1, #2, #3).
HR-ESI-MS: m/z C23H36N7O14 [M+H]
+ calcd 634.2320, found 634.2321.
Preparation of H2N–Gly–(Ala)3–(Glu)3–OH (3)
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Figure 8.4 Chemical structure of peptide 3
Peptide 3 was obtained using the general procedure described above (Yield: 0.21 g,
55%). 1H-NMR: (600 MHz, DMSO−d6) δH 8.54 (d, JHH = 7.5 Hz, N-H Ala #1),
8.24 (d, JHH = 7.5 Hz, NH Ala #2), 8.21 (d, JHH = 7.5 Hz, NH Glu #3), 7.95 (m,
5H, NH2 Gly; NH Glu #1, #2; NH Ala #3), 4.40 (quin, JHH = 7.2 Hz, CH Ala #1),
4.24 (m, 4H, CH Ala #2, #3; CH Glu #1, #2), 4.16 (m, 1H, CH Glu #3), 3.56
(q, JHH = 5.3 Hz, CH2 Gly), 2.24 (m, 6H, γ-CH2 Glu #1, #2, #3), 1.81 (m, 6H,
β-CH2 Glu #1, #2, #3), 1.19 (m, 9H, CH3 Ala #1, #2, #3);
13C-NMR: (150 MHz,
DMSO−d6) δC 174.0, 173.8, 173.1, 171.8, 171.5, 171.1, 170.5, 170.0, 165.5, 51.7,
51.6, 51.3, 48.1, 48.1, 48.0, 40.1, 30.1, 30.1, 29.9, 27.5, 27.4, 26.2, 18.9, 18.1, 18.1;
HR-ESI-MS: m/z C26H42N7O14 [M+H]
+ calcd 676.2784, found 676.2794; IR (KBr):
νmax 3290, 3085, 2983, 2940, 2637, 1716, 1634, 1533, 1443, 1412, 1338, 1201, 1142,
965, 929, 827, 799 cm−1.
Preparation of H2N–Gly–(Ala)3–Glu–OH (4)
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Figure 8.5 Chemical structure of peptide 4
Peptide 4 was obtained using the general procedure described above (Yield: 0.12
g, 93%). 1H-NMR: (600 MHz, DMSO−d6) δH 8.56 (d, JHH = 7.5 Hz, N-H Ala
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#1), 8.24 (d, JHH = 7.6 Hz, N-H Ala #2), 8.11 (d, JHH = 7.9 Hz, N-H Glu), 7.99
(m, 2H, NH2 Gly), 7.91 (d, JHH = 7.3 Hz, N-H Ala #3), 4.40 (quin, JHH = 7.2
Hz, C-H Ala #1), 4.26 (m, 2H, C-H Ala #2, #3), 4.19 (m, 1H, C-H Glu), 3.56
(q, JHH = 4.9 Hz, CH2 Gly), 2.27 (m, 2H, γ-CH2 Glu), 1.86 (m, 2H, β-CH2 Glu),
1.21 (m, 9H, CH3 Ala #1, #2, #3);
13C-NMR: (150 MHz, DMSO−d6) δC 174.1,
173.5, 172.6, 171.9, 165.9, 51.5, 48.5, 48.3, 48.2, 40.4, 30.4, 26.8, 19.0, 18.6, 18.5;
HR-ESI-MS: m/z C16H27N5O8 [M+H]
+ calcd 418.1932, found 418.1936.
Preparation of H2N–Gly–(Leu)3–(Glu)3–OH (5)
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Figure 8.6 Chemical structure of peptide 5
Peptide 10 was obtained using the general procedure described above (Yield: 0.15
g, 52%). 1H-NMR: (600 MHz, DMSO−d6) δH 8.47 (d, JHH = 8.5 Hz, N-H Leu #1),
8.24 (d, JHH = 8.2 Hz, N-H Leu #2), 8.22 (d, JHH = 7.6 Hz, Glu #3), 7.95 (m, 5H,
NH2 Gly; N-H Glu #1, #2; N-H Ala #3), 4.44 (m, 1H, α-CH Leu #1), 4.28 (m, 3H,
α-CH Leu #2; Leu #3; Glu #2), 4.17 (m, 2H, C-H Glu #1; Glu #3), 3.56 (q, JHH
= 5.6 Hz, α-CH2 Gly), 2.24 (m, 6H, γ-CH2 Glu #1, #2, #3), 1.81 (m, 6H, β-CH2
Glu #1, #2, #3), 1.57 (m, 3H, γ-CH Leu #1, #2, #3), 1.42 (m, 6H β-CH2 Leu #1,
#2, #3), 0.85 (m, 18H, CH3 Leu #1, #2, #3);
13C-NMR: (150 MHz, DMSO−d6)
δC 174.5, 174.4, 174.1, 173.5, 172.0, 171.8, 171.5, 171.1, 165.9, 52.0, 51.7, 51.2, 51.2,
41.9, 40.8, 40.5, 30.5, 30.4, 28.0, 27.8, 26.6, 24.6, 24.5, 24.5, 23.6, 23.4, 22.2, 22.1,
21.9; HR-ESI-MS: m/z C35H60N7O14 [M+H]
+ calcd 802.4193, found 802.4177.
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PBI synthesis procedures
General procedure for peptide-PBI conjugates
Peptide-PBI conjugates were synthesised using the standard method of amine con-
densation reported in the literature for the synthesis of symmetric perylene bisimide
derivatives, developed by Langhals and co-workers.15 A mixture of the relevant pep-
tide sequence, perylene tetracarboxylic dianhydride (PTCDA) and imidazole were
added in a round bottom ﬂask and stirred at 120 ◦C for 24 hours under a nitro-
gen atmosphere, after which the mixture was allowed to cool to 90 ◦C and 3 mL
of water was added under nitrogen and allowed to cool to room temperature. The
dark red solution was acidiﬁed with acetic acid to aﬀord a very ﬁne red precipitate.
This solution was then passed through an HP20ss column with addition of increasing
amounts of water. Once the crude mixture was loaded onto the column, 3% (400 mL
total) and 5% (300 mL) acetic acid washings were passed through the column. The
column was then washed with acetone and the desired product was extracted from
the column by rinsing the column with pyridine, subsequently removing the solvent
via reduced pressure.
Preparation of (H2N-Gly-(Glu)3)2–PBI (6)
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Gly Gly (Glu)3(Glu)3
Figure 8.7 Chemical structure of peptide-PBI 6
Peptide-PBI 6 was synthesised using the general procedure outlined above, using
0.0925 g (0.20 mmol) peptide 1, 0.0392 g (0.10 mmol) PTCDA, and 2.0198 g imida-
zole (Yield: 0.09 g, 88%). MALDI-TOF-MS: m/z C58H56N8O26Na [M+Na]
+ calcd
1303, found 1303; IR (KBr): νmax 3430, 3064, 2956, 2925, 2853, 1693, 1658, 1593,
1438, 1401, 1365, 1340, 1302, 1275, 1248, 1174, 1132, 1003, 810 cm−1.
Preparation of (H2N–Gly–(Gly)3–(Glu)3)2–PBI (7)
Peptide-PBI 7 was synthesised using the general procedure outlined above, using
0.1482 g (0.23 mmol) peptide 2, 0.0518 g (0.13 mmol) PTCDA, and 2.3496 g imi-
dazole (Yield: 0.15 g, 70%). 1H-NMR: (600 MHz, CDCl3/CF3COOH, 2:1) δH 8.84
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NN
O
O
O
O
Gly Gly (Gly)3 (Glu)3(Gly)3(Glu)3
Figure 8.8 Chemical structure of peptide-PBI 7
(m, Ar-H), 5.22 (m, α-CH2 Gly), 4.31 (m, α-CH Gly, Glu), 2.31 (m, γ-CH2 Glu),
1.54 (m, β-CH2 Glu); MALDI-TOF-MS:m/z C70H74N14O32Na [M+Na]
+ calcd 1645,
found 1645; IR (KBr): νmax 3424, 2918, 2848, 1692, 1659, 1594, 1440, 1402, 1385,
1366, 1249, 1175, 1121, 1040, 811 cm−1.
Preparation of (H2N–Gly–(Ala)3–(Glu)3)2–PBI (8)
NN
O
O
O
O
Gly Gly (Ala)3 (Glu)3(Ala)3(Glu)3
Figure 8.9 Chemical structure of peptide-PBI 8
Peptide-PBI 8 was synthesised using the general procedure outlined above, using
0.191 g (0.28 mmol) peptide 3, 0.0597 g (0.15 mmol) PTCDA, and 2.049 g imidazole
(Yield: 0.20 g, 84%). 1H-NMR: (600 MHz, CDCl3/CF3COOD, 2:1) δH 8.84 (m, Ar-
H), 5.12 (m,α-CH2 Gly), 4.65 (m, α-CH Ala, Glu), 2.35 (m, γ- and β-CH2 Glu),
1.31 (m,CH3 Ala); MALDI-TOF-MS: m/z C76H86N14O32Na [M+Na]
+ calcd 1730,
found 1730; IR (KBr): νmax 3432, 3295, 3070, 2930, 1693, 1661, 1634, 1595, 1578,
1545, 1440, 1402, 1384, 1367, 1341, 1304, 1249, 1175, 858 cm−1.
Preparation of (H2N–Gly–(Ala)3–(Glu))2–PBI (9)
NN
O
O
O
O
Gly Gly (Ala)3 Glu(Ala)3Glu
Figure 8.10 Chemical structure of peptide-PBI 9
Peptide-PBI 9 was synthesised using the general procedure outlined above, using
0.1002 g (0.24 mmol) peptide 4, 0.0471 g (0.12 mmol) PTCDA, and 4.66 g imidazole
(Yield: 0.11 g, 74%). 1H-NMR: (600 MHz, CDCl3/CF3COOH, 2:1) δH 8.83 (m, Ar-
H), 7.65 (m, N-H Ala, Glu), 5.15 (m, α-CH2 Gly), 4.70 (m, α-CH Ala, Glu), 2.43
(m, γ-CH2 Glu), 2.14 (m, β-CH2 Glu), 1.49 (m, CH3 Ala); MALDI-TOF-MS: m/z
84
C56H58N10O20Na [M+Na]
+ calcd 1213, found 1214; IR (KBr): νmax 3445, 3280,
3060, 2965, 2928, 1698, 1658, 1630, 1594, 1543, 1439, 1401, 1364, 1340, 1302, 1245,
1172, 1054, 853, 810 cm−1.
Preparation of (H2N–Gly–(Leu)3–(Glu)3)2–PBI (10)
NN
O
O
O
O
Gly Gly (Leu)3 (Glu)3(Leu)3(Glu)3
Figure 8.11 Chemical structure of peptide-PBI 10
Peptide-PBI 10 was synthesised using the general procedure outlined above, using
0.1441 g (0.18 mmol) peptide 5, 0.0353 g (0.09 mmol) PTCDA, and 2.2023 g imi-
dazole (Yield: 0.12 g, 71%). 1H-NMR: (600 MHz, CDCl3/CF3COOH, 2:1) δH 8.86
(m, Ar-H), 5.15 (m, α-CH2 Gly), 4.67 (m, α-CH Leu, Glu) 2.63 (m, γ-CH2 Glu),
2.16 (m, β-CH2 Glu), 1.63 (m, β-CH2 Leu; γ-CH Leu), 0.90 (m, CH3 Leu); MALDI-
TOF-MS: m/z C94H122N14O32Na [M+Na]
+ calcd 1982, found 1982; IR (KBr): νmax
3426, 3291, 3074, 2959, 2931, 2872, 1703, 1663, 1642, 1595, 1542, 1438, 1402, 1369,
1341, 1248, 1174, 1130, 1038, 1002, 811 cm−1.
Preparation of (C12H25)2–PBI (11)
N N
O
O
O
O
C12H25 C12H25
Figure 8.12 Chemical structure of alkyl-PBI 11
Alkyl-PBI 11 was synthesised following a similar condensation method reported
by Balakrishnan et al. .23 A mixture of PTCDA (3.92 g, 10 mmol), dodecylamine
(5.53g, 30 mmol), Zn(OAc)2 (0.988 g) and imidazole (40.6 g) were stirred at 130
◦C
for 24 hours under argon atmosphere. The mixture was cooled to room temperature
and dispersed in 500 mL ethanol, and acidiﬁed using 2 m HCl until pH 3–4 was
reached. A red/brown waxy solid was collected via vacuum ﬁltration and dried in
an oven overnight at 120 ◦C. (Yield: 6.8 g, 93.6%). 1H-NMR: (600 MHz, CDCl3) δH
8.77 (d, JHH = 7.9 Hz, Ar-H), 8.66 (d, JHH = 8.1 Hz, Ar-H), 4.21 (t, JHH = 7.7 Hz,
α-CH2), 1.47 (m, 40H, CH2), 0.83 (m, 6H, CH3);
13C-NMR: (150 MHz, CDCl3) δC
163.4, 134.7, 131.5, 123.3, 123.1, 40.7, 31.9, 29.7, 29.7, 29.6, 29.6, 29.4, 27.2, 22.7,
14.1; HR-ESI-MS: m/z C48H58N2O4Na [M+Na]
+ calcd 749.4294, found 749.4315;
85
IR (KBr): νmax 3426, 3070, 2957, 2923, 2850, 1697, 1657, 1594, 1439, 1405, 1345,
1255, 1090, 853, 809, 747 cm−1.
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Appendix - NMR Spectra
This appendix contains NMR spectra of peptide-PBI 8, which was used for structural
identity conﬁrmation. Additionally, the NMR spectra of peptide 3 are included for
illustration of the data used for structural elucidation of each peptide precursor
used in this study. The data for these two compounds are representative of all
data obtained for the peptide-PBI conjugates and peptide precursors respectively.
All data that are reported, but not presented in this appendix, are available upon
request.
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